{"liver fibrosis": {"28785771": {"general_index": ["Gender", "Age", "Race"], "liver_function": ["AST", "ALT"], "title": "Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial.", "max_IF": 19.384, "min_IF": 16.44, "Sample Size": 600, "disease_history": ["Cirrhosis", "HIV genotype", "HCV genotype"], "Impact Factor": 17.91, "Data-Publication": 2017, "Citations": 73, "blood_test": ["CD4+"], "Tumor_test": [], "Test Items": ["AST", "ALT", "CD4+"], "Journal": "Ann Intern Med"}, "28844410": {"general_index": ["Gender", "Age", "Race"], "liver_function": [], "title": "Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/\u03b2-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial.", "max_IF": 6.68, "min_IF": 6.183, "Sample Size": 14, "disease_history": ["HCV genotype"], "Impact Factor": 6.43, "Data-Publication": 2017, "Citations": 11, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "EBioMedicine"}, "27379386": {"general_index": ["BMI", "Gender", "Age", "Blood pressure"], "liver_function": ["Albumin", "ALT", "BUN", "Cholesterol", "AST", "Bilirubin"], "title": "Predictive factors of the pharmacological action of tolvaptan in patients with liver cirrhosis: a post hoc analysis", "max_IF": 3.632, "min_IF": 3.322, "Sample Size": 152, "disease_history": [], "Impact Factor": 3.48, "Data-Publication": 2017, "Citations": 9, "blood_test": ["Serum albumin"], "Tumor_test": [], "Test Items": ["Albumin", "ALT", "BUN", "Cholesterol", "AST", "Bilirubin", "Serum albumin"], "Journal": "J Gastroenterol"}, "27663604": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Bilirubin", "Cholesterol", "Albumin"], "title": "Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.", "max_IF": 20.773, "min_IF": 18.187, "Sample Size": 62, "disease_history": ["Hepatitis C"], "Impact Factor": 19.48, "Data-Publication": 2017, "Citations": 109, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Bilirubin", "Cholesterol", "Albumin", "PLT"], "Journal": "Gastroenterology"}, "26990427": {"general_index": ["Gender", "Age"], "liver_function": ["Bilirubin", "ALT", "CRE", "Albumin", "AST"], "title": "The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver Disease.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 150, "disease_history": ["Cirrhosis", "Obesity", "Hypertension"], "Impact Factor": 2.91, "Data-Publication": 2016, "Citations": 18, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "CRE", "Albumin", "AST", "PLT"], "Journal": "PLoS One"}, "30180806": {"general_index": ["Gender", "Age"], "liver_function": ["Cholesterol"], "title": "Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia.", "max_IF": 2.731, "min_IF": 2.101, "Sample Size": 230, "disease_history": ["Hepatities B", "Hepatitis C"], "Impact Factor": 2.42, "Data-Publication": 2018, "Citations": 1, "blood_test": [], "Tumor_test": [], "Test Items": ["Cholesterol"], "Journal": "BMC Gastroenterol"}, "27645244": {"general_index": ["BMI", "Age"], "liver_function": [], "title": "Pharmacokinetics of the New Hepatitis C Virus NS3 Protease Inhibitor Narlaprevir following Single-Dose Use with or without Ritonavir in Patients with Liver Cirrhosis.", "max_IF": 4.715, "min_IF": 4.255, "Sample Size": 32, "disease_history": [], "Impact Factor": 4.48, "Data-Publication": 2016, "Citations": 6, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Antimicrob Agents Chemother"}, "27917405": {"general_index": [], "liver_function": [], "title": "Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study.", "max_IF": 12.856, "min_IF": 12.856, "Sample Size": 0, "disease_history": [], "Impact Factor": 12.86, "Data-Publication": 2016, "Citations": 52, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Lancet Gastroenterol Hepatol"}, "29672891": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["Albumin"], "title": "Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 100, "disease_history": ["HCV genotype"], "Impact Factor": 13.34, "Data-Publication": 2018, "Citations": 37, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Albumin", "PLT"], "Journal": "Hepatology"}, "27928110": {"general_index": [], "liver_function": ["Albumin", "GGT", "\u03b3-GTP", "ALT", "CHE", "AST", "Bilirubin"], "title": "Stable Liver Function during Long-Term Administration of Eltrombopag, a Thrombopoietin Receptor Agonist, in Patients with Chronic Liver Disease.", "max_IF": 1.584, "min_IF": 1.278, "Sample Size": 5, "disease_history": [], "Impact Factor": 1.43, "Data-Publication": 2016, "Citations": 1, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Albumin", "GGT", "\u03b3-GTP", "ALT", "CHE", "AST", "Bilirubin", "PLT"], "Journal": "Tohoku J Exp Med"}, "26147154": {"general_index": ["BMI", "Gender", "Age"], "liver_function": [], "title": "Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b-infected Japanese patients with or without cirrhosis", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 363, "disease_history": ["HCV genotype"], "Impact Factor": 13.34, "Data-Publication": 2015, "Citations": 130, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Hepatology"}, "26166077": {"general_index": ["Gender", "Age"], "liver_function": ["Cholesterol"], "title": "1H Magnetic Resonance Spectroscopy Predicts Hepatocellular Carcinoma in a Subset of Patients With Liver Cirrhosis: A Randomized Trial.", "max_IF": 6.13, "min_IF": 1.63, "Sample Size": 60, "disease_history": [], "Impact Factor": 3.88, "Data-Publication": 2015, "Citations": 9, "blood_test": [], "Tumor_test": [], "Test Items": ["Cholesterol"], "Journal": "Medicine (Baltimore)"}, "28318147": {"general_index": ["Gender", "Age"], "liver_function": ["Bilirubin", "Cholesterol", "Albumin"], "title": "Effects of alfapump\u2122 system on kidney and circulatory function in patients with cirrhosis and refractory ascites", "max_IF": 4.159, "min_IF": 3.752, "Sample Size": 10, "disease_history": ["Hepatitis C"], "Impact Factor": 3.96, "Data-Publication": 2017, "Citations": 8, "blood_test": ["Serum albumin"], "Tumor_test": [], "Test Items": ["Bilirubin", "Cholesterol", "Albumin", "Serum albumin"], "Journal": "Liver Transpl"}, "27677886": {"general_index": ["Gender", "Age"], "liver_function": [], "title": "Utility of [18F]FSPG PET to Image Hepatocellular Carcinoma: First Clinical Evaluation in a US Population.", "max_IF": 3.608, "min_IF": 2.569, "Sample Size": 11, "disease_history": ["Cirrhosis"], "Impact Factor": 3.09, "Data-Publication": 2016, "Citations": 15, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Mol Imaging Biol"}, "27893675": {"general_index": ["BMI", "Age"], "liver_function": ["AlkP", "ALP", "GGT", "ALT", "AST", "Bilirubin"], "title": "A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis.", "max_IF": 6.13, "min_IF": 1.63, "Sample Size": 199, "disease_history": [], "Impact Factor": 3.88, "Data-Publication": 2016, "Citations": 4, "blood_test": ["APRI"], "Tumor_test": [], "Test Items": ["AlkP", "ALP", "GGT", "ALT", "AST", "Bilirubin", "APRI"], "Journal": "Medicine (Baltimore)"}, "26560052": {"general_index": ["Gender", "Age", "Race"], "liver_function": [], "title": "Longitudinal assessment of hepatitis C fibrosis progression by collagen and smooth muscle actin morphometry in comparison to serum markers.", "max_IF": 7.731, "min_IF": 6.32, "Sample Size": 201, "disease_history": [], "Impact Factor": 7.03, "Data-Publication": 2016, "Citations": 1, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Aliment Pharmacol Ther"}, "26822022": {"general_index": ["Gender", "Age", "Race"], "liver_function": ["Albumin"], "title": "Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+).", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 50, "disease_history": ["Cirrhosis", "HCV genotype"], "Impact Factor": 13.34, "Data-Publication": 2016, "Citations": 210, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Albumin", "PLT"], "Journal": "Hepatology"}, "26764182": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Bilirubin", "CRE", "Albumin", "AST"], "title": "Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids.", "max_IF": 20.773, "min_IF": 18.187, "Sample Size": 136, "disease_history": [], "Impact Factor": 19.48, "Data-Publication": 2016, "Citations": 50, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Bilirubin", "CRE", "Albumin", "AST", "PLT"], "Journal": "Gastroenterology"}, "28165543": {"general_index": [], "liver_function": [], "title": "Effect of nucleoside analogues in the treatment of hepatitis B cirrhosis and its effect on Th17 cell", "max_IF": 2.721, "min_IF": 1.575, "Sample Size": 117, "disease_history": [], "Impact Factor": 2.15, "Data-Publication": 2017, "Citations": 2, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Eur Rev Med Pharmacol Sci"}, "27992614": {"general_index": [], "liver_function": ["GGT"], "title": "A Single Nucleotide Polymorphism in the RASGRF2 Gene Is Associated with Alcoholic Liver Cirrhosis in Men.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 301, "disease_history": [], "Impact Factor": 2.91, "Data-Publication": 2016, "Citations": 0, "blood_test": [], "Tumor_test": [], "Test Items": ["GGT"], "Journal": "PLoS One"}, "27685251": {"general_index": ["BMI", "Gender", "Age", "Waist circumference"], "liver_function": ["HDL", "GLU", "ALT", "GGT", "AST"], "title": "Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients.", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 274, "disease_history": ["Hypertension"], "Impact Factor": 13.34, "Data-Publication": 2017, "Citations": 16, "blood_test": ["cholesterol", "Insulin"], "Tumor_test": [], "Test Items": ["HDL", "GLU", "ALT", "GGT", "AST", "cholesterol", "Insulin"], "Journal": "Hepatology"}, "26575258": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.", "max_IF": 79.258, "min_IF": 59.558, "Sample Size": 818, "disease_history": ["HCV genotype"], "Impact Factor": 69.41, "Data-Publication": 2015, "Citations": 577, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "N Engl J Med"}, "30013913": {"general_index": ["BMI"], "liver_function": [], "title": "Which of the branched-chain amino acids increases cerebral blood flow in hepatic encephalopathy? A double-blind randomized trial.", "max_IF": 4.348, "min_IF": 3.857, "Sample Size": 27, "disease_history": [], "Impact Factor": 4.1, "Data-Publication": 2018, "Citations": 1, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Neuroimage Clin"}, "29778606": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Cholesterol"], "title": "Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.", "max_IF": 20.773, "min_IF": 18.187, "Sample Size": 435, "disease_history": ["HCC"], "Impact Factor": 19.48, "Data-Publication": 2018, "Citations": 23, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Cholesterol", "PLT"], "Journal": "Gastroenterology"}, "27164900": {"general_index": ["BMI", "Age"], "liver_function": [], "title": "[(68)Ga]NODAGA-RGD - Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and\u00a0liver cirrhosis.", "max_IF": 7.704, "min_IF": 5.537, "Sample Size": 9, "disease_history": ["Fatty live", "HCC", "Hepatitis C"], "Impact Factor": 6.62, "Data-Publication": 2016, "Citations": 13, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Eur J Nucl Med Mol Imaging"}, "30379862": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["HDL", "LDL", "ALP", "GLU", "ALT", "AST", "Bilirubin"], "title": "Altered hepatic genes related to retinol metabolism and plasma retinol in patients with non-alcoholic fatty liver disease.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 22, "disease_history": ["Smoking", "NAFLD"], "Impact Factor": 2.91, "Data-Publication": 2018, "Citations": 0, "blood_test": ["cholesterol", "Insulin"], "Tumor_test": [], "Test Items": ["HDL", "LDL", "ALP", "GLU", "ALT", "AST", "Bilirubin", "cholesterol", "Insulin"], "Journal": "PLoS One"}, "27367724": {"general_index": ["Age"], "liver_function": ["HDL", "Albumin", "ALP", "GLU", "GGT", "ALT", "Cholesterol", "AST", "Bilirubin", "TRIG"], "title": "Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis.", "max_IF": 4.196, "min_IF": 3.55, "Sample Size": 49, "disease_history": ["Obesity", "Hypertension", "Hypertriglyceridemia"], "Impact Factor": 3.87, "Data-Publication": 2016, "Citations": 26, "blood_test": ["cholesterol", "PLT", "Insulin"], "Tumor_test": [], "Test Items": ["HDL", "Albumin", "ALP", "GLU", "GGT", "ALT", "Cholesterol", "AST", "Bilirubin", "TRIG", "cholesterol", "PLT", "Insulin"], "Journal": "Nutrients"}, "25985734": {"general_index": ["Gender", "Age", "Race"], "liver_function": ["Cholesterol", "CHE"], "title": "Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease", "max_IF": 20.773, "min_IF": 18.187, "Sample Size": 337, "disease_history": ["Cirrhosis", "HCV genotype"], "Impact Factor": 19.48, "Data-Publication": 2015, "Citations": 619, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Cholesterol", "CHE", "PLT"], "Journal": "Gastroenterology"}, "26874076": {"general_index": ["BMI", "Gender", "Age", "Waist circumference", "Race"], "liver_function": ["HDL", "AlkP", "LDL", "ALP", "GGT", "ALT", "AST", "Bilirubin"], "title": "Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-\u03b1 and -\u03b4, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.", "max_IF": 20.773, "min_IF": 18.187, "Sample Size": 274, "disease_history": ["Cardiovascular disease"], "Impact Factor": 19.48, "Data-Publication": 2016, "Citations": 343, "blood_test": ["glucose", "Triglycerides", "cholesterol", "Hb", "Insulin"], "Tumor_test": [], "Test Items": ["HDL", "AlkP", "LDL", "ALP", "GGT", "ALT", "AST", "Bilirubin", "glucose", "Triglycerides", "cholesterol", "Hb", "Insulin"], "Journal": "Gastroenterology"}, "26465792": {"general_index": ["BMI", "Gender", "Age", "Heigth", "Body Composition"], "liver_function": ["Cholesterol"], "title": "Choline Supplementation With a Structured Lipid in Children With Cystic Fibrosis: A Randomized Placebo-Controlled Trial.", "max_IF": 3.015, "min_IF": 2.4, "Sample Size": 110, "disease_history": [], "Impact Factor": 2.71, "Data-Publication": 2016, "Citations": 8, "blood_test": [], "Tumor_test": [], "Test Items": ["Cholesterol"], "Journal": "J Pediatr Gastroenterol Nutr"}, "26418670": {"general_index": ["Age"], "liver_function": [], "title": "Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience.", "max_IF": 2.629, "min_IF": 2.152, "Sample Size": 161, "disease_history": ["HCV genotype"], "Impact Factor": 2.39, "Data-Publication": 2016, "Citations": 17, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Scand J Gastroenterol"}, "27192671": {"general_index": ["Gender", "Age"], "liver_function": [], "title": "Danazol Treatment for Telomere Diseases.", "max_IF": 79.258, "min_IF": 59.558, "Sample Size": 27, "disease_history": ["Cirrhosis"], "Impact Factor": 69.41, "Data-Publication": 2016, "Citations": 141, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["PLT"], "Journal": "N Engl J Med"}, "28628033": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["HDL", "DBIL", "Albumin", "LDL", "GLU", "GGT", "ALT", "AST", "Bilirubin"], "title": "Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis.", "max_IF": 12.784, "min_IF": 12.282, "Sample Size": 95, "disease_history": ["NAFLD", "Hypertension"], "Impact Factor": 12.53, "Data-Publication": 2017, "Citations": 25, "blood_test": ["Triglycerides", "APRI", "Hb", "Insulin", "cholesterol", "PLT"], "Tumor_test": [], "Test Items": ["HDL", "DBIL", "Albumin", "LDL", "GLU", "GGT", "ALT", "AST", "Bilirubin", "Triglycerides", "APRI", "Hb", "Insulin", "cholesterol", "PLT"], "Journal": "J Clin Invest"}, "26476290": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Bilirubin", "Albumin"], "title": "Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12weeks.", "max_IF": 18.946, "min_IF": 10.59, "Sample Size": 60, "disease_history": ["HCV genotype"], "Impact Factor": 14.77, "Data-Publication": 2016, "Citations": 175, "blood_test": ["PLT"], "Tumor_test": ["AFP"], "Test Items": ["Bilirubin", "Albumin", "PLT", "AFP"], "Journal": "J Hepatol"}, "29637511": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["ALT"], "title": "Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study.", "max_IF": 5.49, "min_IF": 1.125, "Sample Size": 206, "disease_history": ["HCV genotype"], "Impact Factor": 3.31, "Data-Publication": 2018, "Citations": 4, "blood_test": [], "Tumor_test": [], "Test Items": ["ALT"], "Journal": "Hepatol Int"}, "25759552": {"general_index": ["Gender", "Age"], "liver_function": [], "title": "Effect of intravariceal sclerotherapy combined with esophageal mucosal sclerotherapy using small-volume sclerosant for cirrhotic patients with high variceal pressure.", "max_IF": 3.411, "min_IF": 2.787, "Sample Size": 38, "disease_history": ["HBV"], "Impact Factor": 3.1, "Data-Publication": 2015, "Citations": 6, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "World J Gastroenterol"}, "28166812": {"general_index": ["Age"], "liver_function": ["Bilirubin"], "title": "Efficacy of high-intensity focused ultrasound-assisted hepatic resection (HIFU-AR) on blood loss reduction in patients with liver metastases requiring hepatectomy: study protocol for a randomized controlled trial.", "max_IF": 2.067, "min_IF": 1.859, "Sample Size": 0, "disease_history": [], "Impact Factor": 1.96, "Data-Publication": 2017, "Citations": 2, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Bilirubin", "PLT"], "Journal": "Trials"}, "27302659": {"general_index": ["Gender", "Age"], "liver_function": [], "title": "Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 12, "disease_history": [], "Impact Factor": 13.34, "Data-Publication": 2017, "Citations": 22, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Hepatology"}, "25747471": {"general_index": ["Gender", "Age"], "liver_function": [], "title": "Risk factors for invasive Cryptococcus neoformans diseases: a case-control study.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 148, "disease_history": ["Diabetes", "Autoimmune diseases", "AIDS", "Cardiovascular disease"], "Impact Factor": 2.91, "Data-Publication": 2015, "Citations": 36, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "PLoS One"}, "25873064": {"general_index": ["Age"], "liver_function": ["Bilirubin"], "title": "Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial.", "max_IF": 2.067, "min_IF": 1.859, "Sample Size": 119, "disease_history": [], "Impact Factor": 1.96, "Data-Publication": 2015, "Citations": 7, "blood_test": [], "Tumor_test": [], "Test Items": ["Bilirubin"], "Journal": "Trials"}, "29538406": {"general_index": ["Gender", "Age"], "liver_function": [], "title": "Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 41, "disease_history": ["HCC", "HBV"], "Impact Factor": 2.91, "Data-Publication": 2018, "Citations": 5, "blood_test": [], "Tumor_test": ["AFP"], "Test Items": ["AFP"], "Journal": "PLoS One"}, "27749900": {"general_index": ["Age", "Region"], "liver_function": [], "title": "A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 206, "disease_history": ["Cirrhosis", "HCV genotype", "Hepatitis C"], "Impact Factor": 2.91, "Data-Publication": 2016, "Citations": 3, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "PLoS One"}, "29020023": {"general_index": ["Gender", "Age"], "liver_function": ["Cholesterol"], "title": "The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention-A pilot study.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 44, "disease_history": ["Cirrhosis", "HCV genotype"], "Impact Factor": 2.91, "Data-Publication": 2017, "Citations": 5, "blood_test": [], "Tumor_test": [], "Test Items": ["Cholesterol"], "Journal": "PLoS One"}, "27348086": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Albumin", "ALP", "GGT", "ALT", "CRE", "Cholesterol", "AST", "Bilirubin"], "title": "Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation", "max_IF": 4.159, "min_IF": 3.752, "Sample Size": 125, "disease_history": ["Cirrhosis", "HCV genotype", "HCC"], "Impact Factor": 3.96, "Data-Publication": 2016, "Citations": 24, "blood_test": [], "Tumor_test": [], "Test Items": ["Albumin", "ALP", "GGT", "ALT", "CRE", "Cholesterol", "AST", "Bilirubin"], "Journal": "Liver Transpl"}, "25468160": {"general_index": ["BMI", "Gender", "Region", "Age", "Waist circumference", "Race", "Blood pressure"], "liver_function": ["HDL", "AlkP", "LDL", "Albumin", "ALP", "ALT", "CRE", "Cholesterol", "UA", "AST", "Bilirubin", "TP"], "title": "Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.", "max_IF": 59.102, "min_IF": 44.002, "Sample Size": 283, "disease_history": ["Diabetes", "NAFLD", "Hypertension", "Cardiovascular disease"], "Impact Factor": 51.55, "Data-Publication": 2015, "Citations": 1017, "blood_test": ["glucose", "WBC", "cholesterol", "PLT", "Insulin"], "Tumor_test": [], "Test Items": ["HDL", "AlkP", "LDL", "Albumin", "ALP", "ALT", "CRE", "Cholesterol", "UA", "AST", "Bilirubin", "TP", "glucose", "WBC", "cholesterol", "PLT", "Insulin"], "Journal": "Lancet"}, "25588713": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infection.", "max_IF": 1.369, "min_IF": 1.032, "Sample Size": 92, "disease_history": ["Diabetes", "HCV genotype"], "Impact Factor": 1.2, "Data-Publication": 2015, "Citations": 3, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Ann Transplant"}, "28061762": {"general_index": ["Gender", "Age"], "liver_function": ["Cholesterol"], "title": "The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease", "max_IF": 2.768, "min_IF": 2.565, "Sample Size": 249, "disease_history": ["Cirrhosis", "HIV genotype", "HCV genotype", "HCC"], "Impact Factor": 2.67, "Data-Publication": 2017, "Citations": 14, "blood_test": [], "Tumor_test": [], "Test Items": ["Cholesterol"], "Journal": "BMC Infect Dis"}, "26926775": {"general_index": [], "liver_function": [], "title": "RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.", "max_IF": 2.067, "min_IF": 1.859, "Sample Size": 0, "disease_history": [], "Impact Factor": 1.96, "Data-Publication": 2016, "Citations": 12, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Trials"}, "25557906": {"general_index": ["Gender", "Age"], "liver_function": ["Albumin", "ALP", "GGT", "ALT", "CRE", "AST", "Bilirubin"], "title": "Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation.", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 104, "disease_history": ["HCV genotype"], "Impact Factor": 13.34, "Data-Publication": 2015, "Citations": 205, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Albumin", "ALP", "GGT", "ALT", "CRE", "AST", "Bilirubin", "PLT"], "Journal": "Hepatology"}, "25850950": {"general_index": ["Age"], "liver_function": ["Cholesterol"], "title": "Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases.", "max_IF": 10.199, "min_IF": 8.738, "Sample Size": 8, "disease_history": [], "Impact Factor": 9.47, "Data-Publication": 2015, "Citations": 146, "blood_test": [], "Tumor_test": ["CEA"], "Test Items": ["Cholesterol", "CEA"], "Journal": "Clin Cancer Res"}, "28533670": {"general_index": [], "liver_function": ["AST", "ALT", "Albumin"], "title": "Diagnostic value of gadobenate dimeglumine-enhanced hepatocyte-phase magnetic resonance imaging in evaluating hepatic fibrosis and hepatitis.", "max_IF": 3.411, "min_IF": 2.787, "Sample Size": 76, "disease_history": [], "Impact Factor": 3.1, "Data-Publication": 2017, "Citations": 3, "blood_test": [], "Tumor_test": [], "Test Items": ["AST", "ALT", "Albumin"], "Journal": "World J Gastroenterol"}, "27816492": {"general_index": ["Gender", "Age"], "liver_function": ["Cholesterol"], "title": "Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma", "max_IF": 18.946, "min_IF": 10.59, "Sample Size": 32, "disease_history": ["Cirrhosis", "HCV genotype", "HBV"], "Impact Factor": 14.77, "Data-Publication": 2017, "Citations": 137, "blood_test": [], "Tumor_test": [], "Test Items": ["Cholesterol"], "Journal": "J Hepatol"}, "27706177": {"general_index": [], "liver_function": [], "title": "Real-Time Shear Wave versus Transient Elastography for Predicting Fibrosis: Applicability, and Impact of Inflammation and Steatosis. A Non-Invasive Comparison.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 0, "disease_history": [], "Impact Factor": 2.91, "Data-Publication": 2016, "Citations": 15, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "PLoS One"}, "29152781": {"general_index": ["BMI", "Gender", "Age"], "liver_function": [], "title": "Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure.", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 91, "disease_history": ["HCV genotype"], "Impact Factor": 13.34, "Data-Publication": 2018, "Citations": 62, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Hepatology"}, "28030579": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 64, "disease_history": ["HCV genotype"], "Impact Factor": 2.91, "Data-Publication": 2016, "Citations": 0, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "PLoS One"}, "28809743": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["GGT", "\u03b3-GTP", "CRE", "Albumin", "ALT"], "title": "Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination", "max_IF": 1.895, "min_IF": 1.576, "Sample Size": 145, "disease_history": ["HCV genotype", "HCC"], "Impact Factor": 1.74, "Data-Publication": 2017, "Citations": 5, "blood_test": ["WBC", "Hb"], "Tumor_test": ["AFP"], "Test Items": ["GGT", "\u03b3-GTP", "CRE", "Albumin", "ALT", "WBC", "Hb", "AFP"], "Journal": "Ann Hepatol"}, "28651304": {"general_index": ["Gender", "Age"], "liver_function": ["Albumin", "ALT", "CRE", "Cholesterol", "AST", "Bilirubin"], "title": "Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study.", "max_IF": 2.968, "min_IF": 2.0, "Sample Size": 64, "disease_history": ["HCV genotype", "HBV"], "Impact Factor": 2.48, "Data-Publication": 2017, "Citations": 6, "blood_test": ["WBC", "PLT"], "Tumor_test": [], "Test Items": ["Albumin", "ALT", "CRE", "Cholesterol", "AST", "Bilirubin", "WBC", "PLT"], "Journal": "Gut Liver"}, "29548345": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["HDL", "LDL"], "title": "A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis.", "max_IF": 2.288, "min_IF": 1.865, "Sample Size": 21, "disease_history": [], "Impact Factor": 2.08, "Data-Publication": 2018, "Citations": 5, "blood_test": ["Triglycerides", "cholesterol"], "Tumor_test": [], "Test Items": ["HDL", "LDL", "Triglycerides", "cholesterol"], "Journal": "BMC Pharmacol Toxicol"}, "26696302": {"general_index": ["Gender", "Age"], "liver_function": ["Bilirubin", "ALT", "Albumin", "AST"], "title": "Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 527, "disease_history": ["HBV"], "Impact Factor": 2.91, "Data-Publication": 2015, "Citations": 2, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "Albumin", "AST", "PLT"], "Journal": "PLoS One"}, "29023915": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Albumin", "ALP", "GGT", "ALT", "AST", "Bilirubin"], "title": "A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis.", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 66, "disease_history": [], "Impact Factor": 13.34, "Data-Publication": 2018, "Citations": 43, "blood_test": ["cholesterol", "PLT"], "Tumor_test": [], "Test Items": ["Albumin", "ALP", "GGT", "ALT", "AST", "Bilirubin", "cholesterol", "PLT"], "Journal": "Hepatology"}, "26176696": {"general_index": ["Gender", "Age"], "liver_function": ["GGT"], "title": "A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 16, "disease_history": [], "Impact Factor": 2.91, "Data-Publication": 2015, "Citations": 10, "blood_test": ["CD4+"], "Tumor_test": [], "Test Items": ["GGT", "CD4+"], "Journal": "PLoS One"}, "26248955": {"general_index": [], "liver_function": ["AST", "ALT", "Bilirubin"], "title": "Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia.", "max_IF": 5.542, "min_IF": 4.116, "Sample Size": 380, "disease_history": [], "Impact Factor": 4.83, "Data-Publication": 2015, "Citations": 14, "blood_test": [], "Tumor_test": [], "Test Items": ["AST", "ALT", "Bilirubin"], "Journal": "Liver Int"}, "26754432": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["CRE", "Cholesterol"], "title": "Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 113, "disease_history": ["HCV genotype"], "Impact Factor": 13.34, "Data-Publication": 2016, "Citations": 349, "blood_test": [], "Tumor_test": [], "Test Items": ["CRE", "Cholesterol"], "Journal": "Hepatology"}, "29469046": {"general_index": ["Gender", "Age", "Race"], "liver_function": ["Bilirubin", "CRE", "Cholesterol", "Albumin"], "title": "Treatment of Type-1 Hepatorenal Syndrome with Pentoxifylline: A Randomized Placebo Controlled Clinical Trial", "max_IF": 1.895, "min_IF": 1.576, "Sample Size": 12, "disease_history": ["Diabetes", "HCV genotype"], "Impact Factor": 1.74, "Data-Publication": 2018, "Citations": 1, "blood_test": [], "Tumor_test": [], "Test Items": ["Bilirubin", "CRE", "Cholesterol", "Albumin"], "Journal": "Ann Hepatol"}, "30600291": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["Albumin"], "title": "Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir \u00b1 Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis", "max_IF": 1.895, "min_IF": 1.576, "Sample Size": 222, "disease_history": ["HCV genotype", "Depression"], "Impact Factor": 1.74, "Data-Publication": 2018, "Citations": 0, "blood_test": ["PLT", "APRI"], "Tumor_test": [], "Test Items": ["Albumin", "PLT", "APRI"], "Journal": "Ann Hepatol"}, "27370878": {"general_index": ["BMI", "Gender", "Age"], "liver_function": [], "title": "An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial", "max_IF": 3.634, "min_IF": 3.15, "Sample Size": 63, "disease_history": [], "Impact Factor": 3.39, "Data-Publication": 2016, "Citations": 62, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "J Rheumatol"}, "28465443": {"general_index": ["Gender", "Age"], "liver_function": ["Cholesterol"], "title": "Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma.", "max_IF": 10.199, "min_IF": 8.738, "Sample Size": 25, "disease_history": ["Cirrhosis"], "Impact Factor": 9.47, "Data-Publication": 2017, "Citations": 16, "blood_test": [], "Tumor_test": [], "Test Items": ["Cholesterol"], "Journal": "Clin Cancer Res"}, "25261839": {"general_index": ["Gender", "Age", "Race"], "liver_function": ["ALT", "Cholesterol"], "title": "Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.", "max_IF": 20.773, "min_IF": 18.187, "Sample Size": 104, "disease_history": ["HCV genotype"], "Impact Factor": 19.48, "Data-Publication": 2015, "Citations": 318, "blood_test": [], "Tumor_test": [], "Test Items": ["ALT", "Cholesterol"], "Journal": "Gastroenterology"}, "29259382": {"general_index": ["BMI", "Gender", "Age", "Blood pressure"], "liver_function": ["Bilirubin", "ALT", "Cholesterol", "Albumin", "BUN"], "title": "Efficacy of combination therapy with natriuretic and aquaretic drugs in cirrhotic ascites patients: A randomized study.", "max_IF": 3.411, "min_IF": 2.787, "Sample Size": 56, "disease_history": ["HCV genotype", "HBV"], "Impact Factor": 3.1, "Data-Publication": 2017, "Citations": 7, "blood_test": ["Serum albumin", "PLT"], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "Cholesterol", "Albumin", "BUN", "Serum albumin", "PLT"], "Journal": "World J Gastroenterol"}, "29020583": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["Cholesterol"], "title": "Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment.", "max_IF": 79.258, "min_IF": 59.558, "Sample Size": 104, "disease_history": ["HCV genotype"], "Impact Factor": 69.41, "Data-Publication": 2017, "Citations": 172, "blood_test": [], "Tumor_test": [], "Test Items": ["Cholesterol"], "Journal": "N Engl J Med"}, "26122937": {"general_index": ["Gender", "Age"], "liver_function": [], "title": "Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.", "max_IF": 2.731, "min_IF": 2.101, "Sample Size": 90, "disease_history": ["Cirrhosis"], "Impact Factor": 2.42, "Data-Publication": 2015, "Citations": 13, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "MC Gastroenterol"}, "27765759": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["AST", "ALT"], "title": "Fibrogenesis assessed by serological type III collagen formation identifies patients with progressive liver fibrosis and responders to a potential antifibrotic therapy.", "max_IF": 3.729, "min_IF": 3.293, "Sample Size": 198, "disease_history": [], "Impact Factor": 3.51, "Data-Publication": 2016, "Citations": 33, "blood_test": [], "Tumor_test": [], "Test Items": ["AST", "ALT"], "Journal": "Am J Physiol Gastrointest\u00a0Liver\u00a0Physiol"}, "29587697": {"general_index": ["BMI", "Age"], "liver_function": ["Cholesterol"], "title": "Association between skirt size and chronic liver disease in post-menopausal women: a prospective cohort study within the United Kingdom Trial of Ovarian Cancer Screening (UKCTOCS).", "max_IF": 2.567, "min_IF": 2.209, "Sample Size": 124, "disease_history": ["Diabetes", "Hypertension", "Smoking", "Alcohol consumption"], "Impact Factor": 2.39, "Data-Publication": 2018, "Citations": 0, "blood_test": ["cholesterol"], "Tumor_test": [], "Test Items": ["Cholesterol", "cholesterol"], "Journal": "BMC Public Health"}, "25613115": {"general_index": ["BMI", "Gender", "Age"], "liver_function": [], "title": "Association between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study.", "max_IF": 5.057, "min_IF": 3.622, "Sample Size": 1514, "disease_history": ["Smoking"], "Impact Factor": 4.34, "Data-Publication": 2015, "Citations": 8, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Cancer Epidemiol Biomarkers Prev"}, "25591505": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study.", "max_IF": 59.102, "min_IF": 44.002, "Sample Size": 60, "disease_history": ["HCV genotype"], "Impact Factor": 51.55, "Data-Publication": 2015, "Citations": 132, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Lancet"}, "24849310": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["GGT", "ALT", "AST"], "title": "Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity.", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 59, "disease_history": [], "Impact Factor": 13.34, "Data-Publication": 2015, "Citations": 40, "blood_test": [], "Tumor_test": [], "Test Items": ["GGT", "ALT", "AST"], "Journal": "Hepatology"}, "25795699": {"general_index": ["BMI", "Age"], "liver_function": ["AST", "Cholesterol"], "title": "REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial.", "max_IF": 2.562, "min_IF": 2.369, "Sample Size": 81, "disease_history": ["Alcohol consumption", "NAFLD", "HCV genotype", "Hepatitis C", "Cirrhosis"], "Impact Factor": 2.47, "Data-Publication": 2015, "Citations": 28, "blood_test": ["PLT", "APRI"], "Tumor_test": [], "Test Items": ["AST", "Cholesterol", "PLT", "APRI"], "Journal": "BMJ Open"}, "27896822": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["Albumin"], "title": "Simeprevir in combination with sofosbuvir in treatment-na\u00efve and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO)", "max_IF": 7.731, "min_IF": 6.32, "Sample Size": 40, "disease_history": ["Cirrhosis", "HCV genotype"], "Impact Factor": 7.03, "Data-Publication": 2017, "Citations": 29, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Albumin", "PLT"], "Journal": "Aliment Pharmacol Ther"}, "28659136": {"general_index": ["BMI"], "liver_function": [], "title": "Risk of chronic liver disease in post-menopausal women due to body mass index, alcohol and their interaction: a prospective nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).", "max_IF": 2.567, "min_IF": 2.209, "Sample Size": 325, "disease_history": ["Diabetes", "Hypertension", "Smoking", "Alcohol consumption"], "Impact Factor": 2.39, "Data-Publication": 2017, "Citations": 6, "blood_test": ["cholesterol"], "Tumor_test": [], "Test Items": ["cholesterol"], "Journal": "BMC Public Health"}, "27905560": {"general_index": ["Gender", "Age"], "liver_function": ["Bilirubin", "ALT", "Cholesterol", "Albumin", "AST"], "title": "Increased EMR2 expression on neutrophils correlates with disease severity and predicts overall mortality in cirrhotic patients.", "max_IF": 5.228, "min_IF": 4.011, "Sample Size": 0, "disease_history": ["HCV genotype", "HBV"], "Impact Factor": 4.62, "Data-Publication": 2016, "Citations": 5, "blood_test": ["WBC", "PLT"], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "Cholesterol", "Albumin", "AST", "WBC", "PLT"], "Journal": "Sci Rep"}, "30144431": {"general_index": ["Gender", "Age"], "liver_function": ["Bilirubin", "ALT", "Cholesterol", "Albumin", "AST"], "title": "Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis", "max_IF": 20.773, "min_IF": 18.187, "Sample Size": 291, "disease_history": [], "Impact Factor": 19.48, "Data-Publication": 2018, "Citations": 17, "blood_test": ["Serum albumin", "PLT", "WBC"], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "Cholesterol", "Albumin", "AST", "Serum albumin", "PLT", "WBC"], "Journal": "Gastroenterology"}, "25135867": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["Bilirubin", "ALT", "Albumin", "AST"], "title": "Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C.", "max_IF": 18.946, "min_IF": 10.59, "Sample Size": 543, "disease_history": ["Diabetes", "HCV genotype"], "Impact Factor": 14.77, "Data-Publication": 2015, "Citations": 88, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "Albumin", "AST", "PLT"], "Journal": "J Hepatol"}, "28971875": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without\u00a0Cirrhosis\u00a0Treated with a Simeprevir-Sofosbuvir-Ledipasvir Regimen.", "max_IF": 4.715, "min_IF": 4.255, "Sample Size": 40, "disease_history": ["HCV genotype"], "Impact Factor": 4.48, "Data-Publication": 2017, "Citations": 1, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Antimicrob Agents Chemother"}, "25562318": {"general_index": ["Gender", "Age"], "liver_function": ["Albumin", "ALP", "ALT", "CRE", "Cholesterol", "AST", "Bilirubin"], "title": "Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis", "max_IF": 12.784, "min_IF": 12.282, "Sample Size": 134, "disease_history": ["Cirrhosis"], "Impact Factor": 12.53, "Data-Publication": 2015, "Citations": 73, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Albumin", "ALP", "ALT", "CRE", "Cholesterol", "AST", "Bilirubin", "PLT"], "Journal": "J Clin Invest"}, "25914474": {"general_index": ["Age", "Race"], "liver_function": ["Bilirubin", "ALT", "Albumin"], "title": "Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.", "max_IF": 3.411, "min_IF": 2.787, "Sample Size": 305, "disease_history": ["HBV"], "Impact Factor": 3.1, "Data-Publication": 2015, "Citations": 18, "blood_test": [], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "Albumin"], "Journal": "World J Gastroenterol"}, "28523596": {"general_index": ["Gender", "Age"], "liver_function": [], "title": "Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment.", "max_IF": 3.008, "min_IF": 2.737, "Sample Size": 31, "disease_history": ["HCC"], "Impact Factor": 2.87, "Data-Publication": 2017, "Citations": 7, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Cancer Chemother Pharmacol"}, "30067745": {"general_index": ["Gender", "Age", "Race"], "liver_function": ["Bilirubin", "ALT", "CRE", "Albumin", "AST"], "title": "A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 1600, "disease_history": ["Alcohol consumption", "Cirrhosis", "HCV genotype"], "Impact Factor": 2.91, "Data-Publication": 2018, "Citations": 2, "blood_test": ["PLT", "APRI"], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "CRE", "Albumin", "AST", "PLT", "APRI"], "Journal": "PLoS One"}, "29806520": {"general_index": ["Gender", "Age"], "liver_function": ["Bilirubin", "ALT", "Cholesterol", "Albumin", "AST"], "title": "Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis.", "max_IF": 1.431, "min_IF": 1.023, "Sample Size": 67, "disease_history": [], "Impact Factor": 1.23, "Data-Publication": 2018, "Citations": 2, "blood_test": [], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "Cholesterol", "Albumin", "AST"], "Journal": "J Int Med Res"}, "27444413": {"general_index": ["BMI", "Age", "Race"], "liver_function": ["ALT"], "title": "Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.", "max_IF": 9.117, "min_IF": 8.216, "Sample Size": 818, "disease_history": ["Anxiety or panic disorders", "HCV genotype", "fatigue", "Sleep disorders", "Cirrhosis", "Depression"], "Impact Factor": 8.67, "Data-Publication": 2016, "Citations": 43, "blood_test": [], "Tumor_test": [], "Test Items": ["ALT"], "Journal": "Clin Infect Dis"}, "28638828": {"general_index": ["Gender", "Age"], "liver_function": ["AST", "ALT", "Cholesterol", "Albumin"], "title": "Surveillance Program for Diagnosis of HCC in Liver Cirrhosis: Role of Ultrasound Echo Patterns.", "max_IF": 2.583, "min_IF": 2.134, "Sample Size": 359, "disease_history": ["Diabetes"], "Impact Factor": 2.36, "Data-Publication": 2017, "Citations": 2, "blood_test": ["PLT"], "Tumor_test": ["AFP"], "Test Items": ["AST", "ALT", "Cholesterol", "Albumin", "PLT", "AFP"], "Journal": "Biomed Res Int"}, "25111174": {"general_index": ["Gender", "Age"], "liver_function": ["Bilirubin", "ALT", "CRE", "Albumin", "AST"], "title": "Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis.", "max_IF": 18.946, "min_IF": 10.59, "Sample Size": 24, "disease_history": ["HCV genotype"], "Impact Factor": 14.77, "Data-Publication": 2015, "Citations": 47, "blood_test": [], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "CRE", "Albumin", "AST"], "Journal": "J Hepatol"}, "27375283": {"general_index": ["Gender", "Age", "Race"], "liver_function": ["Bilirubin", "ALT", "Albumin", "AST"], "title": "Long-term lamivudine therapy in chronic hepatitis B", "max_IF": 7.731, "min_IF": 6.32, "Sample Size": 22, "disease_history": ["Cirrhosis", "HBV"], "Impact Factor": 7.03, "Data-Publication": 2016, "Citations": 4, "blood_test": ["PLT", "APRI"], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "Albumin", "AST", "PLT", "APRI"], "Journal": "Aliment Pharmacol Ther"}, "27896858": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "Efficacy and safety of simeprevir and sofosbuvir with and without ribavirin in subjects with recurrent genotype 1 hepatitis C postorthotopic liver transplant: the randomized GALAXY study.", "max_IF": 3.526, "min_IF": 2.835, "Sample Size": 46, "disease_history": ["HCV genotype"], "Impact Factor": 3.18, "Data-Publication": 2017, "Citations": 16, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Transpl Int"}, "26571066": {"general_index": ["BMI", "Gender", "Age", "Region", "Race"], "liver_function": [], "title": "Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection.", "max_IF": 79.258, "min_IF": 59.558, "Sample Size": 740, "disease_history": ["HCV genotype"], "Impact Factor": 69.41, "Data-Publication": 2015, "Citations": 660, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "N Engl J Med"}, "27308647": {"general_index": ["BMI", "Gender", "Age", "Waist circumference"], "liver_function": ["GGT", "ALT", "AST", "TRIG"], "title": "Liver Stiffness Evaluation by Transient Elastography in Type 2 Diabetes Mellitus Patients with Ultrasound-proven Steatosis.", "max_IF": 2.063, "min_IF": 1.837, "Sample Size": 298, "disease_history": ["Hypertension", "Hypertriglyceridemia"], "Impact Factor": 1.95, "Data-Publication": 2016, "Citations": 12, "blood_test": ["Triglycerides", "Hb"], "Tumor_test": [], "Test Items": ["GGT", "ALT", "AST", "TRIG", "Triglycerides", "Hb"], "Journal": "J Gastrointestin Liver Dis"}, "26998739": {"general_index": ["Gender", "Age", "Race", "Region"], "liver_function": ["TRIG"], "title": "Outcomes of Lung Transplantation in Recipients With Hepatitis C Virus Infection.", "max_IF": 7.163, "min_IF": 5.669, "Sample Size": 470, "disease_history": ["HCV genotype"], "Impact Factor": 6.42, "Data-Publication": 2016, "Citations": 12, "blood_test": [], "Tumor_test": [], "Test Items": ["TRIG"], "Journal": "Am J Transplant"}, "28056030": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Na\u00efve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 67, "disease_history": ["HCV genotype"], "Impact Factor": 2.91, "Data-Publication": 2017, "Citations": 5, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "PLoS One"}, "28081567": {"general_index": ["Gender", "Age"], "liver_function": [], "title": "Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort Study.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 3556, "disease_history": ["Diabetes"], "Impact Factor": 2.91, "Data-Publication": 2017, "Citations": 2, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "PLoS One"}, "28954926": {"general_index": ["Age"], "liver_function": ["Cholesterol", "HBeAg"], "title": "RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg", "max_IF": 17.161, "min_IF": 16.264, "Sample Size": 2466, "disease_history": ["HBV"], "Impact Factor": 16.71, "Data-Publication": 2017, "Citations": 76, "blood_test": [], "Tumor_test": [], "Test Items": ["Cholesterol", "HBeAg"], "Journal": "Sci Transl Med"}, "25156780": {"general_index": ["Gender", "Age"], "liver_function": ["Albumin", "ALP", "GGT", "ALT", "AST", "Bilirubin"], "title": "Branched-chain amino acids reduce hepatic iron accumulation and oxidative stress in hepatitis C virus polyprotein-expressing mice.", "max_IF": 5.542, "min_IF": 4.116, "Sample Size": 25, "disease_history": [], "Impact Factor": 4.83, "Data-Publication": 2015, "Citations": 11, "blood_test": ["WBC", "PLT", "Insulin"], "Tumor_test": ["AFP"], "Test Items": ["Albumin", "ALP", "GGT", "ALT", "AST", "Bilirubin", "WBC", "PLT", "Insulin", "AFP"], "Journal": "Liver Int"}, "25598080": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["AST", "GLU", "AlkP", "Bilirubin", "ALT"], "title": "Biomarkers of NAFLD progression: a lipidomics approach to an epidemic", "max_IF": 4.81, "min_IF": 4.368, "Sample Size": 88, "disease_history": [], "Impact Factor": 4.59, "Data-Publication": 2015, "Citations": 108, "blood_test": [], "Tumor_test": [], "Test Items": ["AST", "GLU", "AlkP", "Bilirubin", "ALT"], "Journal": "J Lipid Res"}, "28412755": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Cholesterol"], "title": "Randomized clinical trial comparing the effects of sevoflurane and propofol on carbon dioxide embolism during pneumoperitoneum in laparoscopic hepatectomy.", "max_IF": 5.168, "min_IF": 0.0, "Sample Size": 49, "disease_history": ["Cirrhosis"], "Impact Factor": 2.58, "Data-Publication": 2017, "Citations": 5, "blood_test": [], "Tumor_test": [], "Test Items": ["Cholesterol"], "Journal": "Oncotarget"}, "29468557": {"general_index": [], "liver_function": [], "title": "Shear wave elastography in the diagnostics of parathyroid adenomas-new application of the method.", "max_IF": 3.296, "min_IF": 3.131, "Sample Size": 100, "disease_history": [], "Impact Factor": 3.21, "Data-Publication": 2018, "Citations": 1, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Endocrine"}, "26398503": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["GLU", "Bilirubin", "Albumin"], "title": "Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced\u00a0Fibrosis\u00a0or\u00a0Cirrhosis.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 1772, "disease_history": ["HCV genotype"], "Impact Factor": 2.91, "Data-Publication": 2015, "Citations": 2, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["GLU", "Bilirubin", "Albumin", "PLT"], "Journal": "PLoS One"}, "29493105": {"general_index": ["BMI", "Gender", "Age", "Fat Mass", "Body Composition", "Waist circumference", "Heigth"], "liver_function": [], "title": "Probiotic supplementation increases obesity with no detectable effects on liver fat or gut microbiota in obese Hispanic adolescents: a 16-week, randomized, placebo-controlled trial", "max_IF": 3.98, "min_IF": 3.4, "Sample Size": 20, "disease_history": ["Obesity"], "Impact Factor": 3.69, "Data-Publication": 2018, "Citations": 12, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Pediatr Obes"}, "27875564": {"general_index": ["Gender", "Age"], "liver_function": [], "title": "Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 116, "disease_history": ["HCV genotype"], "Impact Factor": 2.91, "Data-Publication": 2016, "Citations": 4, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "PLoS One"}, "25684666": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["Bilirubin", "ALT", "Albumin", "AST"], "title": "Improvement of predictive models of risk of disease progression in chronic hepatitis C by incorporating longitudinal data.", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 577, "disease_history": ["Diabetes", "HCV genotype"], "Impact Factor": 13.34, "Data-Publication": 2015, "Citations": 17, "blood_test": ["PLT", "APRI"], "Tumor_test": ["AFP"], "Test Items": ["Bilirubin", "ALT", "Albumin", "AST", "PLT", "APRI", "AFP"], "Journal": "Hepatology"}, "26157120": {"general_index": ["Gender", "Age", "Race"], "liver_function": ["ALT"], "title": "Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release.", "max_IF": 4.663, "min_IF": 4.324, "Sample Size": 53, "disease_history": ["HCV genotype"], "Impact Factor": 4.49, "Data-Publication": 2015, "Citations": 11, "blood_test": [], "Tumor_test": [], "Test Items": ["ALT"], "Journal": "J Virol"}, "28120743": {"general_index": ["Gender", "Age"], "liver_function": ["Bilirubin", "ALT", "Cholesterol", "Albumin", "AST"], "title": "Long-Term Follow-Up of Patients After utologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis", "max_IF": 3.477, "min_IF": 2.885, "Sample Size": 19, "disease_history": ["HBV"], "Impact Factor": 3.18, "Data-Publication": 2017, "Citations": 2, "blood_test": ["cholesterol"], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "Cholesterol", "Albumin", "AST", "cholesterol"], "Journal": "Cell Transplant"}, "27014750": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["CRE", "AST"], "title": "Effects of Smoking on Pegylated Interferon alpha 2a and First Generation Protease Inhibitor-based Antiviral Therapy in Na\u00efve Patients Infected with Hepatitis C Virus Genotype 1.", "max_IF": 2.063, "min_IF": 1.837, "Sample Size": 1418, "disease_history": ["Diabetes", "HCV genotype", "Hypertension"], "Impact Factor": 1.95, "Data-Publication": 2016, "Citations": 2, "blood_test": ["APRI"], "Tumor_test": [], "Test Items": ["CRE", "AST", "APRI"], "Journal": "J Gastrointestin Liver Dis"}, "25322962": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis.", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 47, "disease_history": ["HCV genotype"], "Impact Factor": 13.34, "Data-Publication": 2015, "Citations": 140, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Hepatology"}, "29073252": {"general_index": ["BMI", "Age", "Blood pressure"], "liver_function": ["HDL", "LDL", "ALT", "AST", "Bilirubin", "TRIG"], "title": "Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease: A single-blinded prospective mono-center study.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 505, "disease_history": [], "Impact Factor": 2.91, "Data-Publication": 2017, "Citations": 7, "blood_test": ["cholesterol", "Hb", "glucose"], "Tumor_test": [], "Test Items": ["HDL", "LDL", "ALT", "AST", "Bilirubin", "TRIG", "cholesterol", "Hb", "glucose"], "Journal": "PLoS One"}, "27443781": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["AlkP", "ALP", "\u03b3-GTP", "ALT", "HBeAg", "AST"], "title": "Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study", "max_IF": 18.705, "min_IF": 14.722, "Sample Size": 702, "disease_history": ["Alcohol consumption", "Smoking", "HIV genotype", "HCV genotype", "HBV"], "Impact Factor": 16.71, "Data-Publication": 2016, "Citations": 60, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["AlkP", "ALP", "\u03b3-GTP", "ALT", "HBeAg", "AST", "PLT"], "Journal": "Lancet Glob Health"}, "28948366": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Albumin"], "title": "Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis.", "max_IF": 3.632, "min_IF": 3.322, "Sample Size": 219, "disease_history": ["HCV genotype"], "Impact Factor": 3.48, "Data-Publication": 2018, "Citations": 34, "blood_test": ["Serum albumin", "PLT"], "Tumor_test": [], "Test Items": ["Albumin", "Serum albumin", "PLT"], "Journal": "J Gastroenterol"}, "26810999": {"general_index": [], "liver_function": [], "title": "ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial.", "max_IF": 2.562, "min_IF": 2.369, "Sample Size": 0, "disease_history": [], "Impact Factor": 2.47, "Data-Publication": 2016, "Citations": 6, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "BMJ Open"}, "26352813": {"general_index": ["Gender", "Age", "Race", "Heigth"], "liver_function": ["HDL", "AST", "ALT", "LDL", "Bilirubin"], "title": "A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency", "max_IF": 79.258, "min_IF": 59.558, "Sample Size": 66, "disease_history": ["Cirrhosis"], "Impact Factor": 69.41, "Data-Publication": 2015, "Citations": 147, "blood_test": ["Triglycerides", "cholesterol"], "Tumor_test": [], "Test Items": ["HDL", "AST", "ALT", "LDL", "Bilirubin", "Triglycerides", "cholesterol"], "Journal": "N Engl J Med"}, "25547503": {"general_index": ["Gender", "Age"], "liver_function": ["Cholesterol"], "title": "SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma.", "max_IF": 28.245, "min_IF": 20.982, "Sample Size": 720, "disease_history": ["Hepatities B", "Cirrhosis", "Smoking", "Hepatitis C"], "Impact Factor": 24.61, "Data-Publication": 2015, "Citations": 287, "blood_test": [], "Tumor_test": [], "Test Items": ["Cholesterol"], "Journal": "J Clin Oncol"}, "28243060": {"general_index": ["BMI", "Gender", "Age", "Race", "Heigth"], "liver_function": [], "title": "Pharmacokinetics of conivaptan use in patients with severe hepatic impairment.", "max_IF": 3.208, "min_IF": 2.822, "Sample Size": 17, "disease_history": [], "Impact Factor": 3.02, "Data-Publication": 2017, "Citations": 2, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Drug Des Devel Ther"}, "29045448": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 27, "disease_history": ["HCV genotype"], "Impact Factor": 2.91, "Data-Publication": 2017, "Citations": 2, "blood_test": ["CD4+"], "Tumor_test": [], "Test Items": ["CD4+"], "Journal": "PLoS One"}, "27593544": {"general_index": ["Gender", "Age"], "liver_function": ["Bilirubin", "ALT", "Albumin", "AST"], "title": "Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis", "max_IF": 7.731, "min_IF": 6.32, "Sample Size": 131, "disease_history": ["HCV genotype"], "Impact Factor": 7.03, "Data-Publication": 2016, "Citations": 31, "blood_test": [], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "Albumin", "AST"], "Journal": "Aliment Pharmacol Ther"}, "27011355": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Bilirubin", "CRE", "Cholesterol", "Albumin"], "title": "Effects of an Exercise Programme on Functional Capacity, Body Composition and Risk of Falls in Patients with Cirrhosis: A Randomized Clinical Trial", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 23, "disease_history": ["Obesity"], "Impact Factor": 2.91, "Data-Publication": 2016, "Citations": 33, "blood_test": [], "Tumor_test": [], "Test Items": ["Bilirubin", "CRE", "Cholesterol", "Albumin"], "Journal": "PLoS One"}, "27776008": {"general_index": ["Gender", "Age", "Race"], "liver_function": [], "title": "Key Histopathologic Features of Liver Biopsies That Distinguish Biliary Atresia From Other Causes of Infantile Cholestasis and Their Correlation With Outcome: A Multicenter Study.", "max_IF": 6.155, "min_IF": 4.951, "Sample Size": 543, "disease_history": [], "Impact Factor": 5.55, "Data-Publication": 2016, "Citations": 20, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Am J Surg Pathol"}, "25582524": {"general_index": ["Gender", "Age", "Race"], "liver_function": ["AST", "ALT", "Albumin"], "title": "Quantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease.", "max_IF": 3.914, "min_IF": 3.537, "Sample Size": 15, "disease_history": ["Cirrhosis", "HCV genotype"], "Impact Factor": 3.73, "Data-Publication": 2015, "Citations": 29, "blood_test": ["WBC"], "Tumor_test": [], "Test Items": ["AST", "ALT", "Albumin", "WBC"], "Journal": "J Proteomics"}, "27151177": {"general_index": [], "liver_function": ["LDL", "GLU", "ALT", "GGT", "AST", "Bilirubin"], "title": "Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial", "max_IF": 18.946, "min_IF": 10.59, "Sample Size": 51, "disease_history": [], "Impact Factor": 14.77, "Data-Publication": 2016, "Citations": 116, "blood_test": ["Triglycerides", "cholesterol", "Insulin"], "Tumor_test": [], "Test Items": ["LDL", "GLU", "ALT", "GGT", "AST", "Bilirubin", "Triglycerides", "cholesterol", "Insulin"], "Journal": "J Hepatol"}, "25611592": {"general_index": ["Gender", "Age"], "liver_function": ["AST", "GGT", "ALT", "Albumin", "ALP"], "title": "Deficiency in thrombopoietin induction after liver surgery is associated with postoperative liver dysfunction.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 69, "disease_history": [], "Impact Factor": 2.91, "Data-Publication": 2015, "Citations": 8, "blood_test": ["PLT", "RBC"], "Tumor_test": [], "Test Items": ["AST", "GGT", "ALT", "Albumin", "ALP", "PLT", "RBC"], "Journal": "PLoS One"}, "26528818": {"general_index": ["Age"], "liver_function": [], "title": "Evaluation of Transient Elastography, Acoustic Radiation Force Impulse Imaging (ARFI), and Enhanced Liver Function (ELF) Score for Detection of Fibrosis in Morbidly Obese Patients.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 41, "disease_history": [], "Impact Factor": 2.91, "Data-Publication": 2015, "Citations": 14, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "PLoS One"}, "26062731": {"general_index": ["Gender", "Age"], "liver_function": ["Bilirubin", "ALT", "Albumin", "AST"], "title": "The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency.", "max_IF": 4.963, "min_IF": 4.211, "Sample Size": 90, "disease_history": [], "Impact Factor": 4.59, "Data-Publication": 2015, "Citations": 23, "blood_test": ["Serum albumin", "PLT"], "Tumor_test": ["AFP"], "Test Items": ["Bilirubin", "ALT", "Albumin", "AST", "Serum albumin", "PLT", "AFP"], "Journal": "Stem Cell Res Ther"}, "25849338": {"general_index": ["Age"], "liver_function": [], "title": "Liver-to-plasma vaniprevir (MK-7009) concentration ratios in HCV-infected patients.", "max_IF": 2.916, "min_IF": 2.146, "Sample Size": 3, "disease_history": ["HCV genotype"], "Impact Factor": 2.53, "Data-Publication": 2015, "Citations": 8, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Antivir Ther"}, "8051800": {"general_index": ["Gender", "Age"], "liver_function": [], "title": "Minimal hepatic encephalopathy in cirrhosis- how long to treat?", "max_IF": 1.895, "min_IF": 1.576, "Sample Size": 112, "disease_history": ["Hepatities B", "Diabetes", "NAFLD", "Hepatitis C", "Cirrhosis"], "Impact Factor": 1.74, "Data-Publication": 2017, "Citations": 12, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Ann Hepatol"}, "26947424": {"general_index": ["Gender", "Age"], "liver_function": ["Bilirubin", "CRE", "Cholesterol", "Albumin"], "title": "Differential visceral blood flow in the hyperdynamic circulation of patients with liver cirrhosis.", "max_IF": 7.731, "min_IF": 6.32, "Sample Size": 40, "disease_history": [], "Impact Factor": 7.03, "Data-Publication": 2016, "Citations": 19, "blood_test": [], "Tumor_test": [], "Test Items": ["Bilirubin", "CRE", "Cholesterol", "Albumin"], "Journal": "Aliment Pharmacol Ther"}, "25130937": {"general_index": ["Gender", "Age"], "liver_function": ["Bilirubin", "CRE", "Cholesterol", "Albumin"], "title": "Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis.", "max_IF": 7.958, "min_IF": 7.398, "Sample Size": 188, "disease_history": ["HCV genotype"], "Impact Factor": 7.68, "Data-Publication": 2015, "Citations": 72, "blood_test": ["WBC", "PLT"], "Tumor_test": [], "Test Items": ["Bilirubin", "CRE", "Cholesterol", "Albumin", "WBC", "PLT"], "Journal": "Clin Gastroenterol Hepatol"}, "25997043": {"general_index": ["BMI", "Gender", "Age", "Waist circumference"], "liver_function": ["AST", "ALT", "CK"], "title": "A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease.", "max_IF": 6.13, "min_IF": 1.63, "Sample Size": 74, "disease_history": ["NAFLD"], "Impact Factor": 3.88, "Data-Publication": 2015, "Citations": 36, "blood_test": ["MPO"], "Tumor_test": ["CK-18"], "Test Items": ["AST", "ALT", "CK", "MPO", "CK-18"], "Journal": "Medicine (Baltimore)"}, "26799692": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study.", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 155, "disease_history": ["HCV genotype"], "Impact Factor": 13.34, "Data-Publication": 2016, "Citations": 172, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Hepatology"}, "26024529": {"general_index": [], "liver_function": [], "title": "Chronic Hepatitis B Virus Infection: The Relation between Hepatitis B Antigen Expression, Telomere Length, Senescence, Inflammation and Fibrosis.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 146, "disease_history": [], "Impact Factor": 2.91, "Data-Publication": 2015, "Citations": 14, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "PLoS One"}, "28480218": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["AlkP", "DBIL", "Albumin", "ALP", "GGT", "\u03b3-GTP", "ALT", "AST", "Bilirubin"], "title": "Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease", "max_IF": 2.583, "min_IF": 2.134, "Sample Size": 23, "disease_history": ["HIV genotype", "HCV genotype", "Hepatitis C"], "Impact Factor": 2.36, "Data-Publication": 2017, "Citations": 11, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["AlkP", "DBIL", "Albumin", "ALP", "GGT", "\u03b3-GTP", "ALT", "AST", "Bilirubin", "PLT"], "Journal": "Biomed Res Int"}, "26759172": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["ALT", "HBeAg"], "title": "Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment na\u00efve and experienced HIV co-infected Ghanaian patients.", "max_IF": 2.768, "min_IF": 2.565, "Sample Size": 235, "disease_history": [], "Impact Factor": 2.67, "Data-Publication": 2016, "Citations": 10, "blood_test": [], "Tumor_test": [], "Test Items": ["ALT", "HBeAg"], "Journal": "BMC Infect Dis"}, "28885322": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["HDL", "DBIL", "Albumin", "LDL", "GLU", "GGT", "ALT", "AST", "Bilirubin"], "title": "Is serum high-mobility group box 1 (HMGB-1) level correlated with liver fibrosis in chronic hepatitis B?", "max_IF": 6.13, "min_IF": 1.63, "Sample Size": 95, "disease_history": ["NAFLD", "Hypertension"], "Impact Factor": 3.88, "Data-Publication": 2017, "Citations": 2, "blood_test": ["Triglycerides", "APRI", "Hb", "Insulin", "cholesterol", "PLT"], "Tumor_test": [], "Test Items": ["HDL", "DBIL", "Albumin", "LDL", "GLU", "GGT", "ALT", "AST", "Bilirubin", "Triglycerides", "APRI", "Hb", "Insulin", "cholesterol", "PLT"], "Journal": "Medicine (Baltimore)"}, "30554571": {"general_index": ["Gender", "Age"], "liver_function": ["ALT"], "title": "Treatment of chronic hepatitis B in sub-Saharan Africa: 1-year results of a pilot program in Ethiopia", "max_IF": 9.088, "min_IF": 7.901, "Sample Size": 1303, "disease_history": ["HCV genotype", "HBV"], "Impact Factor": 8.49, "Data-Publication": 2018, "Citations": 1, "blood_test": ["APRI"], "Tumor_test": [], "Test Items": ["ALT", "APRI"], "Journal": "BMC Med"}, "26704148": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["GGT", "Albumin"], "title": "Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST-2).", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 103, "disease_history": ["HCV genotype"], "Impact Factor": 13.34, "Data-Publication": 2016, "Citations": 176, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["GGT", "Albumin", "PLT"], "Journal": "Hepatology"}, "27340749": {"general_index": ["Age"], "liver_function": ["AST", "ALT"], "title": "Clearance of Hepatic Sphingomyelin by Olipudase Alfa Is Associated With Improvement in Lipid Profiles in Acid Sphingomyelinase Deficiency.", "max_IF": 6.155, "min_IF": 4.951, "Sample Size": 60, "disease_history": [], "Impact Factor": 5.55, "Data-Publication": 2016, "Citations": 4, "blood_test": [], "Tumor_test": [], "Test Items": ["AST", "ALT"], "Journal": "Am J Surg Pathol"}, "25942724": {"general_index": ["Age", "Race"], "liver_function": [], "title": "Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis.", "max_IF": 51.273, "min_IF": 37.684, "Sample Size": 120, "disease_history": ["HCV genotype"], "Impact Factor": 44.48, "Data-Publication": 2015, "Citations": 125, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["PLT"], "Journal": "JAMA"}, "27246604": {"general_index": ["Gender", "Age"], "liver_function": ["ALT"], "title": "HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection.", "max_IF": 2.768, "min_IF": 2.565, "Sample Size": 117, "disease_history": ["HCV genotype"], "Impact Factor": 2.67, "Data-Publication": 2016, "Citations": 3, "blood_test": [], "Tumor_test": [], "Test Items": ["ALT"], "Journal": "BMC Infect Dis"}, "26267788": {"general_index": ["Gender", "Age"], "liver_function": ["DBIL", "Albumin", "ALP", "GGT", "\u03b3-GTP", "ALT", "IBIL", "AST", "Bilirubin"], "title": "Splenectomy Improves Hemostatic and Liver Functions in Hepatosplenic Schistosomiasis Mansoni.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 100, "disease_history": [], "Impact Factor": 2.91, "Data-Publication": 2015, "Citations": 11, "blood_test": [], "Tumor_test": [], "Test Items": ["DBIL", "Albumin", "ALP", "GGT", "\u03b3-GTP", "ALT", "IBIL", "AST", "Bilirubin"], "Journal": "PLoS One"}, "26130251": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["Bilirubin", "ALT", "Albumin", "AST"], "title": "A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum \u03b1-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP", "max_IF": 4.021, "min_IF": 3.866, "Sample Size": 53, "disease_history": ["HCV genotype"], "Impact Factor": 3.94, "Data-Publication": 2015, "Citations": 8, "blood_test": ["PLT"], "Tumor_test": ["AFP"], "Test Items": ["Bilirubin", "ALT", "Albumin", "AST", "PLT", "AFP"], "Journal": "Cancer Prev Res (Phila)"}, "26944023": {"general_index": ["Gender", "Age"], "liver_function": ["AST", "ALT", "Albumin"], "title": "Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design.", "max_IF": 2.658, "min_IF": 2.052, "Sample Size": 289, "disease_history": [], "Impact Factor": 2.36, "Data-Publication": 2016, "Citations": 105, "blood_test": ["Serum albumin", "PLT"], "Tumor_test": [], "Test Items": ["AST", "ALT", "Albumin", "Serum albumin", "PLT"], "Journal": "Contemp Clin Trials"}, "26707009": {"general_index": [], "liver_function": [], "title": "High-dose cholecalciferol in critically ill patients with liver cirrhosis.", "max_IF": 1.902, "min_IF": 1.526, "Sample Size": 0, "disease_history": [], "Impact Factor": 1.71, "Data-Publication": 2016, "Citations": 2, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "J Intern Med"}, "26170136": {"general_index": ["BMI", "Age"], "liver_function": [], "title": "Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis.", "max_IF": 20.773, "min_IF": 18.187, "Sample Size": 181, "disease_history": ["HCV genotype"], "Impact Factor": 19.48, "Data-Publication": 2015, "Citations": 73, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Gastroenterology"}, "28369210": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["ALT"], "title": "Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study", "max_IF": 9.117, "min_IF": 8.216, "Sample Size": 106, "disease_history": ["Cirrhosis", "HCV genotype"], "Impact Factor": 8.67, "Data-Publication": 2017, "Citations": 43, "blood_test": ["CD4+"], "Tumor_test": [], "Test Items": ["ALT", "CD4+"], "Journal": "Clin Infect Dis"}, "28420441": {"general_index": ["Gender", "Age"], "liver_function": [], "title": "Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?", "max_IF": 4.963, "min_IF": 4.211, "Sample Size": 58, "disease_history": ["Cirrhosis"], "Impact Factor": 4.59, "Data-Publication": 2017, "Citations": 13, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Stem Cell Res Ther"}, "26413853": {"general_index": [], "liver_function": [], "title": "The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.", "max_IF": 4.116, "min_IF": 3.806, "Sample Size": 0, "disease_history": [], "Impact Factor": 3.96, "Data-Publication": 2016, "Citations": 18, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "J Acquir Immune Defic Syndr"}, "27022224": {"general_index": ["Gender", "Age", "Race"], "liver_function": [], "title": "Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1.", "max_IF": 3.411, "min_IF": 2.787, "Sample Size": 602, "disease_history": ["Cirrhosis", "HCV genotype"], "Impact Factor": 3.1, "Data-Publication": 2016, "Citations": 5, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "World J Gastroenterol"}, "26976799": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Bilirubin", "CRE", "GGT", "Albumin", "CK"], "title": "Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.", "max_IF": 20.773, "min_IF": 18.187, "Sample Size": 20, "disease_history": ["HCV genotype"], "Impact Factor": 19.48, "Data-Publication": 2016, "Citations": 223, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Bilirubin", "CRE", "GGT", "Albumin", "CK", "PLT"], "Journal": "Gastroenterology"}, "26547499": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["ALT"], "title": "Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data.", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 1949, "disease_history": ["Cirrhosis", "HCV genotype"], "Impact Factor": 13.34, "Data-Publication": 2016, "Citations": 54, "blood_test": [], "Tumor_test": [], "Test Items": ["ALT"], "Journal": "Hepatology"}, "27553377": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["GGT"], "title": "Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials.", "max_IF": 9.117, "min_IF": 8.216, "Sample Size": 51, "disease_history": ["Cirrhosis", "HCV genotype"], "Impact Factor": 8.67, "Data-Publication": 2016, "Citations": 60, "blood_test": [], "Tumor_test": [], "Test Items": ["GGT"], "Journal": "Clin Infect Dis"}, "26109814": {"general_index": ["Gender", "Age"], "liver_function": ["Bilirubin", "ALT", "CRE", "Albumin", "AST"], "title": "Autologous mobilized peripheral blood CD34(+) cell infusion in non-viral decompensated liver cirrhosis.", "max_IF": 3.411, "min_IF": 2.787, "Sample Size": 45, "disease_history": [], "Impact Factor": 3.1, "Data-Publication": 2015, "Citations": 6, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "CRE", "Albumin", "AST", "PLT"], "Journal": "World J Gastroenterol"}, "27006950": {"general_index": ["BMI", "Gender", "Age", "Waist circumference"], "liver_function": [], "title": "Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role?", "max_IF": 2.583, "min_IF": 2.134, "Sample Size": 165, "disease_history": ["Diabetes", "Metabolic syndrome", "Dyslipidemia", "Hypertension"], "Impact Factor": 2.36, "Data-Publication": 2016, "Citations": 11, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Biomed Res Int"}, "28805669": {"general_index": ["BMI", "Age", "Waist circumference", "Blood pressure"], "liver_function": ["LDL", "GGT", "\u03b3-GTP", "ALT", "CRE", "AST", "Bilirubin"], "title": "ffect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study", "max_IF": 4.196, "min_IF": 3.55, "Sample Size": 50, "disease_history": [], "Impact Factor": 3.87, "Data-Publication": 2017, "Citations": 15, "blood_test": ["glucose", "Triglycerides", "cholesterol", "Insulin"], "Tumor_test": [], "Test Items": ["LDL", "GGT", "\u03b3-GTP", "ALT", "CRE", "AST", "Bilirubin", "glucose", "Triglycerides", "cholesterol", "Insulin"], "Journal": "Nutrients"}, "28104990": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["HDL", "AlkP", "LDL", "ALP", "GGT", "ALT", "AST"], "title": "Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial.", "max_IF": 3.411, "min_IF": 2.787, "Sample Size": 12, "disease_history": ["Diabetes"], "Impact Factor": 3.1, "Data-Publication": 2017, "Citations": 37, "blood_test": ["glucose", "Triglycerides", "Hb", "PLT"], "Tumor_test": [], "Test Items": ["HDL", "AlkP", "LDL", "ALP", "GGT", "ALT", "AST", "glucose", "Triglycerides", "Hb", "PLT"], "Journal": "World J Gastroenterol"}, "27486034": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["ALT"], "title": "Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial.", "max_IF": 20.773, "min_IF": 18.187, "Sample Size": 199, "disease_history": ["HCV genotype"], "Impact Factor": 19.48, "Data-Publication": 2016, "Citations": 43, "blood_test": [], "Tumor_test": [], "Test Items": ["ALT"], "Journal": "Gastroenterology"}, "30103740": {"general_index": ["Age"], "liver_function": ["Cholesterol"], "title": "Real world evaluation of a novel lateral flow assay (AlphaKit\u00ae QuickScreen) for the detection of alpha-1-antitrypsin deficiency.", "max_IF": 3.841, "min_IF": 3.751, "Sample Size": 1019, "disease_history": [], "Impact Factor": 3.8, "Data-Publication": 2018, "Citations": 2, "blood_test": [], "Tumor_test": [], "Test Items": ["Cholesterol"], "Journal": "Respir Res"}, "26329749": {"general_index": ["Gender", "Age"], "liver_function": ["ALT", "Cholesterol"], "title": "Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B", "max_IF": 3.26, "min_IF": 2.503, "Sample Size": 57, "disease_history": ["HBV"], "Impact Factor": 2.88, "Data-Publication": 2015, "Citations": 14, "blood_test": [], "Tumor_test": [], "Test Items": ["ALT", "Cholesterol"], "Journal": "Adv Ther"}, "27569726": {"general_index": ["BMI", "Gender", "Age", "Waist circumference", "Race", "Blood pressure"], "liver_function": ["HDL", "AlkP", "LDL", "ALP", "ALT", "AST", "Bilirubin"], "title": "In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores.", "max_IF": 20.773, "min_IF": 18.187, "Sample Size": 169, "disease_history": ["Diabetes", "NAFLD", "Hypertension", "Cirrhosis"], "Impact Factor": 19.48, "Data-Publication": 2016, "Citations": 48, "blood_test": ["glucose", "Triglycerides", "cholesterol", "Insulin"], "Tumor_test": [], "Test Items": ["HDL", "AlkP", "LDL", "ALP", "ALT", "AST", "Bilirubin", "glucose", "Triglycerides", "cholesterol", "Insulin"], "Journal": "Gastroenterology"}, "30226889": {"general_index": ["BMI", "Gender", "Age", "Waist circumference"], "liver_function": ["HDL", "LDL", "Albumin", "GLU", "ALT", "GGT"], "title": "Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 295, "disease_history": ["Diabetes", "Obesity", "Dyslipidemia", "Metabolic syndrome"], "Impact Factor": 2.91, "Data-Publication": 2018, "Citations": 0, "blood_test": ["Triglycerides", "cholesterol", "Hb"], "Tumor_test": [], "Test Items": ["HDL", "LDL", "Albumin", "GLU", "ALT", "GGT", "Triglycerides", "cholesterol", "Hb"], "Journal": "PLoS One"}, "25711331": {"general_index": ["Gender", "Age", "Race"], "liver_function": ["AST", "ALT"], "title": "Baseline prevalence and predictors of liver fibrosis among HIV-positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.", "max_IF": 3.734, "min_IF": 2.932, "Sample Size": 230, "disease_history": ["HIV genotype", "HCV genotype", "HBV"], "Impact Factor": 3.33, "Data-Publication": 2015, "Citations": 17, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["AST", "ALT", "PLT"], "Journal": "HIV Med"}, "28875955": {"general_index": ["Gender", "Age"], "liver_function": ["ALT"], "title": "Efficacy of Real-world Entecavir Therapy in Treatment-na\u00efve Chronic Hepatitis B Patients.", "max_IF": 1.596, "min_IF": 0.957, "Sample Size": 233, "disease_history": ["HBV"], "Impact Factor": 1.28, "Data-Publication": 2017, "Citations": 7, "blood_test": [], "Tumor_test": [], "Test Items": ["ALT"], "Journal": "Chin Med J (Engl)"}, "29098441": {"general_index": ["Gender", "Age"], "liver_function": [], "title": "Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial.", "max_IF": 3.252, "min_IF": 2.486, "Sample Size": 38, "disease_history": ["Cirrhosis"], "Impact Factor": 2.87, "Data-Publication": 2017, "Citations": 7, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Med Oncol"}, "24633624": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Cholesterol", "Albumin"], "title": "wo randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment.", "max_IF": 3.632, "min_IF": 3.322, "Sample Size": 16, "disease_history": ["Diabetes", "HCV genotype", "HCC", "HBV"], "Impact Factor": 3.48, "Data-Publication": 2015, "Citations": 11, "blood_test": [], "Tumor_test": [], "Test Items": ["Cholesterol", "Albumin"], "Journal": "J Gastroenterol"}, "26735686": {"general_index": ["Age"], "liver_function": ["HDL", "LDL", "Albumin", "\u03b3-GTP", "Bilirubin", "TRIG"], "title": "Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 10, "disease_history": ["HCV genotype"], "Impact Factor": 2.91, "Data-Publication": 2016, "Citations": 2, "blood_test": ["cholesterol"], "Tumor_test": [], "Test Items": ["HDL", "LDL", "Albumin", "\u03b3-GTP", "Bilirubin", "TRIG", "cholesterol"], "Journal": "PLoS One"}, "29616028": {"general_index": ["Age"], "liver_function": ["GGT", "ALT", "AST"], "title": "Human \u03b3\u03b4 T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy.", "max_IF": 6.429, "min_IF": 4.716, "Sample Size": 33, "disease_history": ["HCV genotype"], "Impact Factor": 5.57, "Data-Publication": 2018, "Citations": 4, "blood_test": [], "Tumor_test": [], "Test Items": ["GGT", "ALT", "AST"], "Journal": "Front Immunol"}, "28564569": {"general_index": ["Gender", "Age", "Race"], "liver_function": ["ALT"], "title": "Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection", "max_IF": 79.258, "min_IF": 59.558, "Sample Size": 748, "disease_history": ["Cirrhosis", "HCV genotype"], "Impact Factor": 69.41, "Data-Publication": 2017, "Citations": 243, "blood_test": [], "Tumor_test": [], "Test Items": ["ALT"], "Journal": "N Engl J Med"}, "27189282": {"general_index": ["Gender", "Age"], "liver_function": ["AST", "ALT"], "title": "Cyclooxygenase-2 Inhibitor Reduces Hepatic Stiffness in Pediatric Chronic Liver Disease Patients Following Kasai Portoenterostomy.", "max_IF": 1.759, "min_IF": 1.154, "Sample Size": 69, "disease_history": [], "Impact Factor": 1.46, "Data-Publication": 2016, "Citations": 46, "blood_test": [], "Tumor_test": [], "Test Items": ["AST", "ALT"], "Journal": "Yonsei Med J"}, "25218788": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["Bilirubin", "ALT", "Albumin"], "title": "Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.", "max_IF": 18.946, "min_IF": 10.59, "Sample Size": 2084, "disease_history": ["HCV genotype"], "Impact Factor": 14.77, "Data-Publication": 2015, "Citations": 88, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "Albumin", "PLT"], "Journal": "J Hepatol"}, "27657493": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Bilirubin", "ALT", "Cholesterol", "Albumin", "CRE"], "title": "MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma.", "max_IF": 22.416, "min_IF": 20.871, "Sample Size": 407, "disease_history": ["Hepatities B", "Hepatitis C"], "Impact Factor": 21.64, "Data-Publication": 2017, "Citations": 40, "blood_test": ["PLT"], "Tumor_test": ["AFP"], "Test Items": ["Bilirubin", "ALT", "Cholesterol", "Albumin", "CRE", "PLT", "AFP"], "Journal": "JAMA Oncol"}, "25292174": {"general_index": ["BMI", "Gender", "Age", "Waist circumference"], "liver_function": ["HDL", "LDL", "Albumin", "ALT", "Cholesterol", "AST"], "title": "Obesity depresses the anti-inflammatory HSP70 pathway, contributing to NAFLD progression.", "max_IF": 4.042, "min_IF": 3.614, "Sample Size": 95, "disease_history": ["Diabetes", "Obesity", "NAFLD"], "Impact Factor": 3.83, "Data-Publication": 2015, "Citations": 44, "blood_test": ["cholesterol", "Hb", "Insulin", "PLT"], "Tumor_test": [], "Test Items": ["HDL", "LDL", "Albumin", "ALT", "Cholesterol", "AST", "cholesterol", "Hb", "Insulin", "PLT"], "Journal": "Obesity (Silver Spring)"}, "28947470": {"general_index": ["Gender", "Age", "Race"], "liver_function": [], "title": "Effect of Hepatic Impairment on the Pharmacokinetics of Grazoprevir, a Hepatitis C Virus Protease Inhibitor.", "max_IF": 4.715, "min_IF": 4.255, "Sample Size": 25, "disease_history": [], "Impact Factor": 4.48, "Data-Publication": 2017, "Citations": 4, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Antimicrob Agents Chemother"}, "27010143": {"general_index": [], "liver_function": [], "title": "Cost-effectiveness of Lamivudine, Telbivudine, Adefovir Dipivoxil and Entecavir on decompensated hepatitis B virus-related cirrhosis.", "max_IF": 2.721, "min_IF": 1.575, "Sample Size": 1332, "disease_history": [], "Impact Factor": 2.15, "Data-Publication": 2016, "Citations": 6, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Eur Rev Med Pharmacol Sci"}, "25957003": {"general_index": ["Gender"], "liver_function": ["Cholesterol"], "title": "Randomized trials of endoscopic therapy and transjugular intrahepatic portosystemic shunt versus portacaval shunt for emergency and elective treatment of bleeding gastric varices in cirrhosis.", "max_IF": 3.526, "min_IF": 2.835, "Sample Size": 1836, "disease_history": ["Cirrhosis"], "Impact Factor": 3.18, "Data-Publication": 2015, "Citations": 20, "blood_test": [], "Tumor_test": [], "Test Items": ["Cholesterol"], "Journal": "Surgery"}, "25500425": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Bilirubin", "Albumin", "ALP"], "title": "Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid", "max_IF": 20.773, "min_IF": 18.187, "Sample Size": 165, "disease_history": [], "Impact Factor": 19.48, "Data-Publication": 2015, "Citations": 353, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Bilirubin", "Albumin", "ALP", "PLT"], "Journal": "Gastroenterology"}, "25613922": {"general_index": ["BMI", "Gender", "Age", "Fat Mass"], "liver_function": ["ALT", "Cholesterol", "Albumin"], "title": "Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 14, "disease_history": [], "Impact Factor": 13.34, "Data-Publication": 2015, "Citations": 77, "blood_test": [], "Tumor_test": [], "Test Items": ["ALT", "Cholesterol", "Albumin"], "Journal": "Hepatology"}, "27743502": {"general_index": [], "liver_function": [], "title": "Modeling and Experimental Studies of Obeticholic Acid Exposure and the Impact of Cirrhosis Stage", "max_IF": 3.989, "min_IF": 0.86, "Sample Size": 0, "disease_history": [], "Impact Factor": 2.42, "Data-Publication": 2016, "Citations": 10, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Clin Transl Sci"}, "25989386": {"general_index": ["Gender", "Age"], "liver_function": ["CRE", "Cholesterol", "Bilirubin"], "title": "Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.", "max_IF": 20.773, "min_IF": 18.187, "Sample Size": 185, "disease_history": [], "Impact Factor": 19.48, "Data-Publication": 2015, "Citations": 97, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["CRE", "Cholesterol", "Bilirubin", "PLT"], "Journal": "Gastroenterology"}, "26468123": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "Selenium deficiency occurs in some patients with moderate-to-severe cirrhosis and can be corrected by administration of selenate but not selenomethionine: a randomized controlled trial", "max_IF": 6.926, "min_IF": 6.549, "Sample Size": 82, "disease_history": [], "Impact Factor": 6.74, "Data-Publication": 2015, "Citations": 10, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Am J Clin Nutr"}, "28470676": {"general_index": ["BMI", "Gender", "Age", "Race", "Heigth"], "liver_function": [], "title": "Acetyl-coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double-blind, crossover study.", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 30, "disease_history": [], "Impact Factor": 13.34, "Data-Publication": 2017, "Citations": 31, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Hepatology"}, "27825963": {"general_index": ["Gender", "Age", "Race"], "liver_function": ["Cholesterol"], "title": "Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma", "max_IF": 20.773, "min_IF": 18.187, "Sample Size": 1800, "disease_history": ["Hepatities B", "Hepatitis C"], "Impact Factor": 19.48, "Data-Publication": 2017, "Citations": 34, "blood_test": [], "Tumor_test": [], "Test Items": ["Cholesterol"], "Journal": "Gastroenterology"}, "26521268": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens.", "max_IF": 9.117, "min_IF": 8.216, "Sample Size": 34, "disease_history": ["HCV genotype"], "Impact Factor": 8.67, "Data-Publication": 2016, "Citations": 38, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Clin Infect Dis"}, "28420329": {"general_index": [], "liver_function": [], "title": "Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial", "max_IF": 3.288, "min_IF": 2.933, "Sample Size": 0, "disease_history": [], "Impact Factor": 3.11, "Data-Publication": 2017, "Citations": 1, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "BMC Cancer"}, "27310371": {"general_index": ["BMI", "Age", "Waist circumference"], "liver_function": ["HDL", "LDL", "GGT", "ALT", "Cholesterol", "AST"], "title": "Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 24, "disease_history": [], "Impact Factor": 2.91, "Data-Publication": 2016, "Citations": 21, "blood_test": ["glucose", "Triglycerides", "cholesterol", "Insulin"], "Tumor_test": [], "Test Items": ["HDL", "LDL", "GGT", "ALT", "Cholesterol", "AST", "glucose", "Triglycerides", "cholesterol", "Insulin"], "Journal": "PLoS One"}, "28644367": {"general_index": ["BMI", "Gender", "Age", "Heigth"], "liver_function": [], "title": "Oral Cholic Acid Is Efficacious and Well Tolerated in Patients With Bile Acid Synthesis and Zellweger Spectrum Disorders.", "max_IF": 3.015, "min_IF": 2.4, "Sample Size": 85, "disease_history": [], "Impact Factor": 2.71, "Data-Publication": 2017, "Citations": 12, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "J Pediatr Gastroenterol Nutr"}, "28419124": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["HDL", "LDL", "ALP", "GLU", "ALT", "GGT", "CRE", "Cholesterol", "AST"], "title": "A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 45, "disease_history": ["Diabetes"], "Impact Factor": 2.91, "Data-Publication": 2017, "Citations": 13, "blood_test": ["cholesterol", "PLT"], "Tumor_test": [], "Test Items": ["HDL", "LDL", "ALP", "GLU", "ALT", "GGT", "CRE", "Cholesterol", "AST", "cholesterol", "PLT"], "Journal": "PLoS One"}, "28658165": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Cholesterol", "Albumin"], "title": "Changes in skeletal muscle mass after endoscopic treatment in patients with esophageal varices.", "max_IF": 6.13, "min_IF": 1.63, "Sample Size": 51, "disease_history": [], "Impact Factor": 3.88, "Data-Publication": 2017, "Citations": 0, "blood_test": ["Serum albumin"], "Tumor_test": [], "Test Items": ["Cholesterol", "Albumin", "Serum albumin"], "Journal": "Medicine (Baltimore)"}, "25627020": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["Bilirubin", "ALT", "Albumin"], "title": "Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir.", "max_IF": 7.731, "min_IF": 6.32, "Sample Size": 2084, "disease_history": ["HCV genotype"], "Impact Factor": 7.03, "Data-Publication": 2015, "Citations": 27, "blood_test": ["Hb", "PLT"], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "Albumin", "Hb", "PLT"], "Journal": "Aliment Pharmacol Ther"}, "30192782": {"general_index": ["BMI", "Gender", "Age", "Heigth"], "liver_function": [], "title": "tility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 30, "disease_history": [], "Impact Factor": 2.91, "Data-Publication": 2018, "Citations": 3, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "PLoS One"}, "30308053": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Bilirubin", "ALT", "CRE", "Albumin", "AST"], "title": "Serum asunaprevir concentrations showing correlation with the extent of liver fibrosis as a factor inducing liver injuries in patients with genotype-1b hepatitis C virus receiving daclatasvir plus asunaprevir therapy.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 278, "disease_history": ["Cirrhosis", "HCV genotype"], "Impact Factor": 2.91, "Data-Publication": 2018, "Citations": 2, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "CRE", "Albumin", "AST", "PLT"], "Journal": "PLoS One"}, "26899745": {"general_index": ["Gender", "Age"], "liver_function": ["CRE", "Cholesterol", "Albumin"], "title": "Similar rebleeding rate in 3-day and 7-day intravenous ceftriaxone prophylaxis for patients with acute variceal bleeding.", "max_IF": 2.844, "min_IF": 1.969, "Sample Size": 71, "disease_history": ["HCV genotype", "HBV"], "Impact Factor": 2.41, "Data-Publication": 2016, "Citations": 0, "blood_test": ["WBC", "PLT"], "Tumor_test": [], "Test Items": ["CRE", "Cholesterol", "Albumin", "WBC", "PLT"], "Journal": "J Formos Med Assoc"}, "27830836": {"general_index": ["BMI", "Age", "Heigth"], "liver_function": ["HDL", "LDL", "GGT", "ALT", "CHE", "Cholesterol", "AST", "TRIG"], "title": "Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial.", "max_IF": 5.228, "min_IF": 4.011, "Sample Size": 280, "disease_history": ["NAFLD"], "Impact Factor": 4.62, "Data-Publication": 2016, "Citations": 6, "blood_test": ["Insulin"], "Tumor_test": [], "Test Items": ["HDL", "LDL", "GGT", "ALT", "CHE", "Cholesterol", "AST", "TRIG", "Insulin"], "Journal": "Sci Rep"}, "29513836": {"general_index": ["Gender", "Age"], "liver_function": [], "title": "Effectiveness of first-wave protease inhibitors in hepatitis C virus genotype 1 infection: a multicenter study in Brazil.", "max_IF": 1.498, "min_IF": 0.949, "Sample Size": 275, "disease_history": [], "Impact Factor": 1.22, "Data-Publication": 2018, "Citations": 1, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Rev Soc Bras Med Trop"}, "25243383": {"general_index": [], "liver_function": [], "title": "Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis.", "max_IF": 5.542, "min_IF": 4.116, "Sample Size": 100, "disease_history": ["HCV genotype", "HBV"], "Impact Factor": 4.83, "Data-Publication": 2015, "Citations": 39, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Liver Int"}, "30508890": {"general_index": ["BMI", "Age", "Heigth"], "liver_function": [], "title": "Computed tomography portography of patients with cirrhosis with normal body mass index: Comparison between low-tube-voltage CT with low contrast agent dose and conventional CT.", "max_IF": 6.13, "min_IF": 1.63, "Sample Size": 118, "disease_history": [], "Impact Factor": 3.88, "Data-Publication": 2018, "Citations": 1, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Medicine (Baltimore)"}, "25644279": {"general_index": ["Gender", "Age"], "liver_function": ["ALT"], "title": "Randomized trial of interferon- and ribavirin-free ombitasvir/paritaprevir/ritonavir in treatment-experienced hepatitis C virus-infected patients", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 144, "disease_history": ["HCV genotype"], "Impact Factor": 13.34, "Data-Publication": 2015, "Citations": 73, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["ALT", "PLT"], "Journal": "Hepatology"}, "28833331": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["AlkP", "\u03b3-GTP", "Bilirubin", "ALP"], "title": "A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis.", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 289, "disease_history": ["NAFLD"], "Impact Factor": 13.34, "Data-Publication": 2018, "Citations": 146, "blood_test": ["Triglycerides", "cholesterol", "Hb"], "Tumor_test": [], "Test Items": ["AlkP", "\u03b3-GTP", "Bilirubin", "ALP", "Triglycerides", "cholesterol", "Hb"], "Journal": "Hepatology"}, "28827788": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["AST", "ALT", "TRIG"], "title": "Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study", "max_IF": 5.228, "min_IF": 4.011, "Sample Size": 58, "disease_history": ["Cirrhosis", "HCV genotype"], "Impact Factor": 4.62, "Data-Publication": 2017, "Citations": 4, "blood_test": [], "Tumor_test": [], "Test Items": ["AST", "ALT", "TRIG"], "Journal": "Sci Rep"}, "27446833": {"general_index": ["Gender", "Age"], "liver_function": ["GGT", "ALT", "AST", "ALP"], "title": "Sofosbuvir-Based Therapy for Genotype 4 HCV Recurrence Post-Liver Transplant Treatment-Experienced Patients", "max_IF": 2.307, "min_IF": 1.622, "Sample Size": 36, "disease_history": ["Diabetes", "Dyslipidemia", "HCV genotype", "Hypertension", "HBV"], "Impact Factor": 1.96, "Data-Publication": 2016, "Citations": 5, "blood_test": [], "Tumor_test": [], "Test Items": ["GGT", "ALT", "AST", "ALP"], "Journal": "Can J Gastroenterol Hepatol"}, "28789631": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["HDL", "GGT", "ALT", "LDL", "AST"], "title": "Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study", "max_IF": 2.731, "min_IF": 2.101, "Sample Size": 29, "disease_history": ["Diabetes", "Dyslipidemia"], "Impact Factor": 2.42, "Data-Publication": 2017, "Citations": 17, "blood_test": ["Triglycerides", "cholesterol", "Hb", "PLT"], "Tumor_test": [], "Test Items": ["HDL", "GGT", "ALT", "LDL", "AST", "Triglycerides", "cholesterol", "Hb", "PLT"], "Journal": "BMC Gastroenterol"}, "30458048": {"general_index": ["BMI", "Gender", "Age", "Waist circumference", "Fat Mass"], "liver_function": ["HDL", "LDL", "Albumin", "GGT", "\u03b3-GTP", "ALT", "UA", "AST"], "title": "One-year weight management lowers lipopolysaccharide-binding protein and its implication in metainflammation and liver fibrosis", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 122, "disease_history": ["Fatty live"], "Impact Factor": 2.91, "Data-Publication": 2018, "Citations": 0, "blood_test": ["Triglycerides", "PLT", "Hb", "Insulin", "cholesterol", "glucose"], "Tumor_test": [], "Test Items": ["HDL", "LDL", "Albumin", "GGT", "\u03b3-GTP", "ALT", "UA", "AST", "Triglycerides", "PLT", "Hb", "Insulin", "cholesterol", "glucose"], "Journal": "PLoS One"}, "28728560": {"general_index": [], "liver_function": [], "title": "Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial", "max_IF": 2.067, "min_IF": 1.859, "Sample Size": 0, "disease_history": [], "Impact Factor": 1.96, "Data-Publication": 2017, "Citations": 7, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Trials"}, "25523381": {"general_index": ["Gender", "Age"], "liver_function": ["Albumin", "ALP", "GGT", "ALT", "CRE", "Cholesterol", "AST", "Bilirubin"], "title": "Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis", "max_IF": 7.731, "min_IF": 6.32, "Sample Size": 272, "disease_history": ["Hepatities B", "Hepatitis C"], "Impact Factor": 7.03, "Data-Publication": 2015, "Citations": 67, "blood_test": [], "Tumor_test": [], "Test Items": ["Albumin", "ALP", "GGT", "ALT", "CRE", "Cholesterol", "AST", "Bilirubin"], "Journal": "Aliment Pharmacol Ther"}, "26503582": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["AST", "\u03b3-GTP", "Albumin", "ALT"], "title": "Serum WFA+\u2010M2BP is a non\u2010invasive liver fibrosis marker that can predict the efficacy of direct\u2010acting anti\u2010viral\u2010based triple therapy for chronic hepatitis C", "max_IF": 7.731, "min_IF": 6.32, "Sample Size": 159, "disease_history": ["HCV genotype"], "Impact Factor": 7.03, "Data-Publication": 2016, "Citations": 22, "blood_test": ["Serum albumin", "PLT"], "Tumor_test": [], "Test Items": ["AST", "\u03b3-GTP", "Albumin", "ALT", "Serum albumin", "PLT"], "Journal": "Aliment Pharmacol Ther"}, "27228119": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["ALT"], "title": "ovariation Analysis of Serumal and Urinary Metabolites Suggests Aberrant Glycine and Fatty Acid Metabolism in Chronic Hepatitis B.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 108, "disease_history": ["HBV"], "Impact Factor": 2.91, "Data-Publication": 2016, "Citations": 1, "blood_test": [], "Tumor_test": [], "Test Items": ["ALT"], "Journal": "PLoS One"}, "26569658": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis", "max_IF": 79.258, "min_IF": 59.558, "Sample Size": 267, "disease_history": ["HCV genotype"], "Impact Factor": 69.41, "Data-Publication": 2015, "Citations": 517, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "N Engl J Med"}, "27611776": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Bilirubin", "ALT", "Cholesterol", "Albumin", "CRE"], "title": "Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir \u00b1 dasabuvir \u00b1 ribavirin in hepatitis C: AMBER study.", "max_IF": 7.731, "min_IF": 6.32, "Sample Size": 209, "disease_history": ["HCV genotype"], "Impact Factor": 7.03, "Data-Publication": 2016, "Citations": 77, "blood_test": ["PLT"], "Tumor_test": ["AFP"], "Test Items": ["Bilirubin", "ALT", "Cholesterol", "Albumin", "CRE", "PLT", "AFP"], "Journal": "Aliment Pharmacol Ther"}, "28301945": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Bilirubin", "CRE", "Cholesterol", "Albumin"], "title": "The utility of the macro-aggregated albumin lung perfusion scan in the diagnosis and prognosis of hepatopulmonary syndrome in cirrhotic patients candidates for liver transplantation", "max_IF": 1.858, "min_IF": 1.401, "Sample Size": 74, "disease_history": ["Alcohol consumption", "Smoking", "HCV genotype", "HBV"], "Impact Factor": 1.63, "Data-Publication": 2017, "Citations": 1, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Bilirubin", "CRE", "Cholesterol", "Albumin", "PLT"], "Journal": "Rev Esp Enferm Dig"}, "25369449": {"general_index": ["BMI", "Age"], "liver_function": [], "title": "High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.", "max_IF": 7.608, "min_IF": 6.798, "Sample Size": 445, "disease_history": ["Diabetes", "Dyslipidemia"], "Impact Factor": 7.2, "Data-Publication": 2015, "Citations": 58, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Radiology"}, "30325939": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 48, "disease_history": [], "Impact Factor": 2.91, "Data-Publication": 2018, "Citations": 1, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "PLoS One"}, "27873094": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["AST", "ALT", "Cholesterol", "Bilirubin", "TRIG"], "title": "The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study.", "max_IF": 3.632, "min_IF": 3.322, "Sample Size": 399, "disease_history": ["Cirrhosis", "HCV genotype"], "Impact Factor": 3.48, "Data-Publication": 2017, "Citations": 42, "blood_test": ["Hb", "PLT"], "Tumor_test": [], "Test Items": ["AST", "ALT", "Cholesterol", "Bilirubin", "TRIG", "Hb", "PLT"], "Journal": "J Gastroenterol"}, "26196665": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.", "max_IF": 79.258, "min_IF": 59.558, "Sample Size": 335, "disease_history": ["Cirrhosis", "HCV genotype"], "Impact Factor": 69.41, "Data-Publication": 2015, "Citations": 398, "blood_test": ["CD4+"], "Tumor_test": [], "Test Items": ["CD4+"], "Journal": "N Engl J Med"}, "26503379": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver Disease.", "max_IF": 9.117, "min_IF": 8.216, "Sample Size": 512, "disease_history": ["HCV genotype"], "Impact Factor": 8.67, "Data-Publication": 2016, "Citations": 23, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Clin Infect Dis"}, "27169903": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "Pharmacokinetics, Safety, and CCR2/CCR5 Antagonist Activity of Cenicriviroc in Participants With Mild or Moderate Hepatic Impairment.", "max_IF": 3.989, "min_IF": 0.86, "Sample Size": 8, "disease_history": ["Hepatities B", "Cirrhosis", "Hepatitis C"], "Impact Factor": 2.42, "Data-Publication": 2016, "Citations": 25, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Clin Transl Sci"}, "25641433": {"general_index": ["Gender", "Age"], "liver_function": [], "title": "Phase II evaluation of IPI-926, an oral Hedgehog inhibitor, in patients with myelofibrosis.", "max_IF": 3.093, "min_IF": 2.644, "Sample Size": 14, "disease_history": [], "Impact Factor": 2.87, "Data-Publication": 2015, "Citations": 41, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["PLT"], "Journal": "Leuk Lymphoma"}, "28245243": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Bilirubin", "CRE", "Cholesterol", "Albumin"], "title": "Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial", "max_IF": 13.585, "min_IF": 11.048, "Sample Size": 40, "disease_history": [], "Impact Factor": 12.32, "Data-Publication": 2017, "Citations": 24, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Bilirubin", "CRE", "Cholesterol", "Albumin", "PLT"], "Journal": "PLoS Med"}, "30576330": {"general_index": ["Gender", "Age"], "liver_function": [], "title": "Local care and treatment of liver disease (LOCATE) - A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary care.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 11352, "disease_history": ["Diabetes"], "Impact Factor": 2.91, "Data-Publication": 2018, "Citations": 2, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "PLoS One"}, "26769835": {"general_index": [], "liver_function": ["AlkP", "Albumin", "ALP", "ALT", "CRE", "AST", "Bilirubin"], "title": "Influence of an upright body position on the size of intrapulmonary blood shunts in patients with advanced liver cirrhosis.", "max_IF": 2.883, "min_IF": 2.478, "Sample Size": 30, "disease_history": [], "Impact Factor": 2.68, "Data-Publication": 2015, "Citations": 4, "blood_test": ["WBC", "PLT", "RBC"], "Tumor_test": [], "Test Items": ["AlkP", "Albumin", "ALP", "ALT", "CRE", "AST", "Bilirubin", "WBC", "PLT", "RBC"], "Journal": "J Physiol Pharmacol"}, "26078579": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["HDL", "LDL", "ALT", "Cholesterol", "AST", "Bilirubin", "TRIG"], "title": "Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis.", "max_IF": 3.411, "min_IF": 2.787, "Sample Size": 78, "disease_history": ["Smoking"], "Impact Factor": 3.1, "Data-Publication": 2015, "Citations": 34, "blood_test": [], "Tumor_test": [], "Test Items": ["HDL", "LDL", "ALT", "Cholesterol", "AST", "Bilirubin", "TRIG"], "Journal": "World J Gastroenterol"}, "26831610": {"general_index": ["BMI", "Gender", "Age", "Waist circumference"], "liver_function": ["HDL", "AlkP", "LDL", "ALP", "GGT", "ALT", "Cholesterol", "AST", "Bilirubin"], "title": "Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial.", "max_IF": 1.704, "min_IF": 1.312, "Sample Size": 30, "disease_history": ["Diabetes", "Obesity", "Hypertension"], "Impact Factor": 1.51, "Data-Publication": 2016, "Citations": 26, "blood_test": ["Triglycerides", "cholesterol"], "Tumor_test": [], "Test Items": ["HDL", "AlkP", "LDL", "ALP", "GGT", "ALT", "Cholesterol", "AST", "Bilirubin", "Triglycerides", "cholesterol"], "Journal": "Saudi J Gastroenterol"}, "26367736": {"general_index": [], "liver_function": ["GLU", "ALT", "GGT", "AST", "TRIG"], "title": "Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study", "max_IF": 2.721, "min_IF": 1.575, "Sample Size": 36, "disease_history": ["NAFLD"], "Impact Factor": 2.15, "Data-Publication": 2015, "Citations": 46, "blood_test": [], "Tumor_test": [], "Test Items": ["GLU", "ALT", "GGT", "AST", "TRIG"], "Journal": "Eur Rev Med Pharmacol Sci"}, "27837387": {"general_index": ["BMI", "Gender", "Age", "Waist circumference"], "liver_function": [], "title": "Vitamin D3 Loading Is Superior to Conventional Supplementation After Weight Loss Surgery in Vitamin D-Deficient Morbidly Obese Patients: a Double-Blind Randomized Placebo-Controlled Trial.", "max_IF": 3.947, "min_IF": 3.346, "Sample Size": 50, "disease_history": ["Diabetes", "Depression"], "Impact Factor": 3.65, "Data-Publication": 2017, "Citations": 15, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Obes Surg"}, "27977757": {"general_index": ["BMI", "Gender", "Age", "Waist circumference"], "liver_function": ["HDL", "LDL", "GLU", "ALT", "GGT", "Cholesterol", "AST"], "title": "Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 23, "disease_history": [], "Impact Factor": 2.91, "Data-Publication": 2016, "Citations": 43, "blood_test": ["Triglycerides", "cholesterol", "Hb", "Insulin"], "Tumor_test": [], "Test Items": ["HDL", "LDL", "GLU", "ALT", "GGT", "Cholesterol", "AST", "Triglycerides", "cholesterol", "Hb", "Insulin"], "Journal": "PLoS One"}, "29365309": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["ALT", "Bilirubin"], "title": "Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.", "max_IF": 79.258, "min_IF": 59.558, "Sample Size": 1208, "disease_history": ["HCV genotype"], "Impact Factor": 69.41, "Data-Publication": 2018, "Citations": 111, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["ALT", "Bilirubin", "PLT"], "Journal": "N Engl J Med"}, "27506549": {"general_index": ["Age"], "liver_function": ["ALT", "HBeAg"], "title": "Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.", "max_IF": 2.768, "min_IF": 2.565, "Sample Size": 328, "disease_history": [], "Impact Factor": 2.67, "Data-Publication": 2016, "Citations": 18, "blood_test": [], "Tumor_test": [], "Test Items": ["ALT", "HBeAg"], "Journal": "BMC Infect Dis"}, "25788199": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Albumin"], "title": "Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years.", "max_IF": 5.49, "min_IF": 1.125, "Sample Size": 634, "disease_history": ["HBV"], "Impact Factor": 3.31, "Data-Publication": 2015, "Citations": 35, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["Albumin", "PLT"], "Journal": "Hepatol Int"}, "27992499": {"general_index": ["Gender", "Age"], "liver_function": ["AST", "ALT", "DBIL", "Bilirubin"], "title": "Diffusion Tensor Imaging for Evaluating Biliary Atresia in Infants and Neonates", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 59, "disease_history": [], "Impact Factor": 2.91, "Data-Publication": 2016, "Citations": 0, "blood_test": [], "Tumor_test": [], "Test Items": ["AST", "ALT", "DBIL", "Bilirubin"], "Journal": "PLoS One"}, "29151701": {"general_index": ["Gender", "Age"], "liver_function": [], "title": "Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy vs transjugular intrahepatic portosystemic shunt in patients with cirrhosis and acute portal vein thrombosis.", "max_IF": 3.411, "min_IF": 2.787, "Sample Size": 40, "disease_history": ["HCV genotype", "HBV"], "Impact Factor": 3.1, "Data-Publication": 2017, "Citations": 3, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "World J Gastroenterol"}, "26835876": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["ALT"], "title": "A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection.", "max_IF": 5.542, "min_IF": 4.116, "Sample Size": 87, "disease_history": ["Cirrhosis", "HCV genotype"], "Impact Factor": 4.83, "Data-Publication": 2016, "Citations": 22, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["ALT", "PLT"], "Journal": "Liver Int"}, "25512403": {"general_index": ["Gender", "Age"], "liver_function": [], "title": "Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis.", "max_IF": 4.715, "min_IF": 4.255, "Sample Size": 362, "disease_history": ["HCV genotype"], "Impact Factor": 4.48, "Data-Publication": 2015, "Citations": 10, "blood_test": ["APRI"], "Tumor_test": [], "Test Items": ["APRI"], "Journal": "Antimicrob Agents Chemother"}, "27805836": {"general_index": ["BMI", "Gender", "Age", "Heigth"], "liver_function": [], "title": "Lumacaftor/Ivacaftor in Patients Aged 6-11 Years with Cystic Fibrosis and Homozygous for F508del-CFTR.", "max_IF": 16.494, "min_IF": 13.118, "Sample Size": 58, "disease_history": [], "Impact Factor": 14.81, "Data-Publication": 2017, "Citations": 69, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Am J Respir Crit Care Med"}, "27532829": {"general_index": ["Gender", "Age"], "liver_function": ["AlkP", "Bilirubin", "ALP"], "title": "A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.", "max_IF": 79.258, "min_IF": 59.558, "Sample Size": 216, "disease_history": [], "Impact Factor": 69.41, "Data-Publication": 2016, "Citations": 331, "blood_test": [], "Tumor_test": [], "Test Items": ["AlkP", "Bilirubin", "ALP"], "Journal": "N Engl J Med"}, "29091342": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "edipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-na\u00efve patients: Findings from two randomized trials.", "max_IF": 5.542, "min_IF": 4.116, "Sample Size": 89, "disease_history": ["HIV genotype", "HCV genotype"], "Impact Factor": 4.83, "Data-Publication": 2018, "Citations": 5, "blood_test": ["CD4+"], "Tumor_test": [], "Test Items": ["CD4+"], "Journal": "Liver Int"}, "29874528": {"general_index": ["Gender", "Age"], "liver_function": ["Bilirubin", "AlkP", "Albumin", "ALP"], "title": "A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis", "max_IF": 79.258, "min_IF": 59.558, "Sample Size": 100, "disease_history": [], "Impact Factor": 69.41, "Data-Publication": 2018, "Citations": 43, "blood_test": ["cholesterol", "PLT"], "Tumor_test": [], "Test Items": ["Bilirubin", "AlkP", "Albumin", "ALP", "cholesterol", "PLT"], "Journal": "N Engl J Med"}, "28660640": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["AST", "ALT", "Albumin"], "title": "Randomised clinical trial: sofosbuvir and ledipasvir in patients with transfusion-dependent thalassaemia and HCV genotype 1 or 4 infection", "max_IF": 7.731, "min_IF": 6.32, "Sample Size": 196, "disease_history": ["Diabetes", "Cirrhosis", "HCV genotype"], "Impact Factor": 7.03, "Data-Publication": 2017, "Citations": 17, "blood_test": ["glucose", "PLT"], "Tumor_test": [], "Test Items": ["AST", "ALT", "Albumin", "glucose", "PLT"], "Journal": "Aliment Pharmacol Ther"}, "25333309": {"general_index": [], "liver_function": [], "title": "Estimating liver perfusion from free-breathing continuously acquired dynamic gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced acquisition with compressed sensing reconstruction.", "max_IF": 6.224, "min_IF": 4.887, "Sample Size": 19, "disease_history": [], "Impact Factor": 5.56, "Data-Publication": 2015, "Citations": 26, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Invest Radiol"}, "27866195": {"general_index": ["Gender", "Age"], "liver_function": ["Bilirubin", "ALT", "Albumin", "HBeAg"], "title": "Comparison of Telbivudine and Entecavir Therapy on Nephritic Function and Drug Resistance in Patients with Hepatitis B Virus-Related Compensated Cirrhosis", "max_IF": 5.5, "min_IF": 4.652, "Sample Size": 70, "disease_history": ["HBV"], "Impact Factor": 5.08, "Data-Publication": 2016, "Citations": 4, "blood_test": [], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "Albumin", "HBeAg"], "Journal": "Cell Physiol Biochem"}, "29329305": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["Bilirubin", "ALT", "Albumin", "HBeAg"], "title": "Evaluating the efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant stable hepatitis B patients.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 169, "disease_history": ["Cirrhosis", "HBV"], "Impact Factor": 2.91, "Data-Publication": 2018, "Citations": 1, "blood_test": ["APRI"], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "Albumin", "HBeAg", "APRI"], "Journal": "PLoS One"}, "29095942": {"general_index": ["Age"], "liver_function": [], "title": "Serum high mobility group box 1 protein levels are not associated with either histological severity or treatment response in children and adults with nonalcoholic fatty liver disease.", "max_IF": 3.057, "min_IF": 2.766, "Sample Size": 316, "disease_history": [], "Impact Factor": 2.91, "Data-Publication": 2017, "Citations": 2, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "PLoS One"}, "27486033": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial.", "max_IF": 20.773, "min_IF": 18.187, "Sample Size": 128, "disease_history": ["HCV genotype"], "Impact Factor": 19.48, "Data-Publication": 2016, "Citations": 46, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Gastroenterology"}, "28233752": {"general_index": ["Gender", "Age"], "liver_function": ["Bilirubin", "Cholesterol", "Albumin"], "title": "A Randomized Controlled Trial of Procedural Techniques for Large Volume Paracentesis.", "max_IF": 1.895, "min_IF": 1.576, "Sample Size": 127, "disease_history": ["HCV genotype", "HBV"], "Impact Factor": 1.74, "Data-Publication": 2017, "Citations": 3, "blood_test": ["PLT"], "Tumor_test": ["AFP"], "Test Items": ["Bilirubin", "Cholesterol", "Albumin", "PLT", "AFP"], "Journal": "Ann Hepatol"}, "27521509": {"general_index": ["BMI", "Age"], "liver_function": ["GGT", "ALT", "Albumin", "AST"], "title": "Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial", "max_IF": 7.958, "min_IF": 7.398, "Sample Size": 24, "disease_history": [], "Impact Factor": 7.68, "Data-Publication": 2017, "Citations": 48, "blood_test": ["cholesterol", "PLT"], "Tumor_test": [], "Test Items": ["GGT", "ALT", "Albumin", "AST", "cholesterol", "PLT"], "Journal": "Clin Gastroenterol Hepatol"}, "26252305": {"general_index": ["Gender", "Age"], "liver_function": ["Cholesterol"], "title": "Heparin Saline Versus Normal Saline for Flushing and Locking Peripheral Venous Catheters in Decompensated Liver Cirrhosis Patients: A Randomized Controlled Trial.", "max_IF": 6.13, "min_IF": 1.63, "Sample Size": 68, "disease_history": [], "Impact Factor": 3.88, "Data-Publication": 2015, "Citations": 5, "blood_test": [], "Tumor_test": [], "Test Items": ["Cholesterol"], "Journal": "Medicine (Baltimore)"}, "27308650": {"general_index": ["Gender", "Age"], "liver_function": ["Cholesterol"], "title": "Prevalence of Helicobacter pylori Infection in Patients with Minimal Hepatic Encephalopathy.", "max_IF": 2.063, "min_IF": 1.837, "Sample Size": 84, "disease_history": ["NAFLD", "HCV genotype", "HBV"], "Impact Factor": 1.95, "Data-Publication": 2016, "Citations": 4, "blood_test": [], "Tumor_test": [], "Test Items": ["Cholesterol"], "Journal": "J Gastrointestin Liver Dis"}, "28687627": {"general_index": ["Age"], "liver_function": ["Bilirubin", "Albumin"], "title": "Phase II Trial of Sorafenib in Combination with Capecitabine in Patients with Hepatocellular Carcinoma: INST 08-20.", "max_IF": 5.306, "min_IF": 4.789, "Sample Size": 13, "disease_history": ["Hepatitis C"], "Impact Factor": 5.05, "Data-Publication": 2017, "Citations": 3, "blood_test": [], "Tumor_test": ["AFP"], "Test Items": ["Bilirubin", "Albumin", "AFP"], "Journal": "Oncologist"}, "29229500": {"general_index": ["BMI", "Age"], "liver_function": ["AST", "ALT", "CHE", "Albumin", "ALP"], "title": "Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma", "max_IF": 3.538, "min_IF": 2.229, "Sample Size": 86, "disease_history": [], "Impact Factor": 2.88, "Data-Publication": 2018, "Citations": 10, "blood_test": ["PLT"], "Tumor_test": ["AFP"], "Test Items": ["AST", "ALT", "CHE", "Albumin", "ALP", "PLT", "AFP"], "Journal": "Int J Infect Dis"}, "27265388": {"general_index": ["BMI", "Gender", "Age", "Waist circumference", "Blood pressure"], "liver_function": ["CK"], "title": "Effects of dark chocolate on NOX-2-generated oxidative stress in patients with non-alcoholic steatohepatitis.", "max_IF": 7.731, "min_IF": 6.32, "Sample Size": 38, "disease_history": ["Diabetes", "Coronary heart disease", "Smoking", "Hypertension"], "Impact Factor": 7.03, "Data-Publication": 2016, "Citations": 9, "blood_test": ["PLT"], "Tumor_test": ["CK-18"], "Test Items": ["CK", "PLT", "CK-18"], "Journal": "Aliment Pharmacol Ther"}, "27439433": {"general_index": [], "liver_function": ["GGT"], "title": "Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial.", "max_IF": 2.067, "min_IF": 1.859, "Sample Size": 60, "disease_history": ["Hepatities B", "HIV genotype", "HCV genotype"], "Impact Factor": 1.96, "Data-Publication": 2016, "Citations": 13, "blood_test": ["Hb", "glucose"], "Tumor_test": ["AFP"], "Test Items": ["GGT", "Hb", "glucose", "AFP"], "Journal": "Trials"}, "25613083": {"general_index": ["Gender", "Age", "Race"], "liver_function": ["Cholesterol"], "title": "Everolimus and pasireotide for advanced and metastatic hepatocellular carcinoma.", "max_IF": 3.502, "min_IF": 2.663, "Sample Size": 24, "disease_history": ["Hepatities B", "Hepatitis C"], "Impact Factor": 3.08, "Data-Publication": 2015, "Citations": 9, "blood_test": [], "Tumor_test": [], "Test Items": ["Cholesterol"], "Journal": "Invest New Drugs"}, "29599611": {"general_index": ["Gender", "Age", "Race"], "liver_function": [], "title": "Daclatasvir plus asunaprevir in treatment-na\u00efve patients with hepatitis C virus genotype 1b infection.", "max_IF": 3.411, "min_IF": 2.787, "Sample Size": 2072, "disease_history": ["Cirrhosis", "HCV genotype"], "Impact Factor": 3.1, "Data-Publication": 2018, "Citations": 3, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "World J Gastroenterol"}, "27232579": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": ["ALT", "AST", "AlkP", "Bilirubin", "ALP"], "title": "Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: results of a 6-month open-label safety trial.", "max_IF": 5.542, "min_IF": 4.116, "Sample Size": 18, "disease_history": ["HIV genotype", "Hepatitis C"], "Impact Factor": 4.83, "Data-Publication": 2016, "Citations": 40, "blood_test": ["PLT"], "Tumor_test": [], "Test Items": ["ALT", "AST", "AlkP", "Bilirubin", "ALP", "PLT"], "Journal": "Liver Int"}, "25529941": {"general_index": ["BMI", "Gender", "Age", "Heigth"], "liver_function": ["GGT", "ALT", "AST"], "title": "Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease.", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 174, "disease_history": [], "Impact Factor": 13.34, "Data-Publication": 2015, "Citations": 65, "blood_test": [], "Tumor_test": [], "Test Items": ["GGT", "ALT", "AST"], "Journal": "Hepatology"}, "28586116": {"general_index": ["Gender", "Age", "Race"], "liver_function": ["AST", "ALT", "Albumin"], "title": "Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial", "max_IF": 14.97, "min_IF": 11.711, "Sample Size": 20, "disease_history": ["Diabetes", "HCV genotype"], "Impact Factor": 13.34, "Data-Publication": 2017, "Citations": 101, "blood_test": ["Serum albumin", "WBC"], "Tumor_test": [], "Test Items": ["AST", "ALT", "Albumin", "Serum albumin", "WBC"], "Journal": "Hepatology"}, "26711747": {"general_index": ["BMI", "Gender", "Age"], "liver_function": [], "title": "Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection.", "max_IF": 4.715, "min_IF": 4.255, "Sample Size": 8, "disease_history": ["HCV genotype"], "Impact Factor": 4.48, "Data-Publication": 2015, "Citations": 33, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Antimicrob Agents Chemother"}, "27184636": {"general_index": ["BMI", "Age"], "liver_function": ["AST", "ALT", "Cholesterol", "Albumin"], "title": "An open-label randomized control study to compare the efficacy of vitamin e versus ursodeoxycholic acid in nondiabetic and noncirrhotic Indian NAFLD patients.", "max_IF": 1.704, "min_IF": 1.312, "Sample Size": 250, "disease_history": [], "Impact Factor": 1.51, "Data-Publication": 2016, "Citations": 11, "blood_test": ["PLT", "Triglycerides", "Hb", "Serum albumin", "APRI"], "Tumor_test": [], "Test Items": ["AST", "ALT", "Cholesterol", "Albumin", "PLT", "Triglycerides", "Hb", "Serum albumin", "APRI"], "Journal": "Saudi J Gastroenterol"}, "27620282": {"general_index": [], "liver_function": [], "title": "echniques of TIPS in the treatment of liver cirrhosis combined with incompletely occlusive main portal vein thrombosis.", "max_IF": 5.228, "min_IF": 4.011, "Sample Size": 183, "disease_history": [], "Impact Factor": 4.62, "Data-Publication": 2016, "Citations": 4, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Sci Rep"}, "29127060": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["AlkP", "Albumin", "ALP", "ALT", "CRE", "Cholesterol", "AST", "Bilirubin"], "title": "Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial.", "max_IF": 12.856, "min_IF": 12.856, "Sample Size": 81, "disease_history": ["Hepatitis C"], "Impact Factor": 12.86, "Data-Publication": 2018, "Citations": 27, "blood_test": ["WBC", "PLT"], "Tumor_test": [], "Test Items": ["AlkP", "Albumin", "ALP", "ALT", "CRE", "Cholesterol", "AST", "Bilirubin", "WBC", "PLT"], "Journal": "Lancet Gastroenterol Hepatol"}, "29266346": {"general_index": ["Gender", "Age"], "liver_function": ["Bilirubin", "ALT", "Cholesterol", "Albumin", "AST"], "title": "Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation", "max_IF": 7.731, "min_IF": 6.32, "Sample Size": 132, "disease_history": ["HCV genotype"], "Impact Factor": 7.03, "Data-Publication": 2018, "Citations": 7, "blood_test": [], "Tumor_test": [], "Test Items": ["Bilirubin", "ALT", "Cholesterol", "Albumin", "AST"], "Journal": "Aliment Pharmacol Ther"}, "26196502": {"general_index": ["Gender", "Age", "Race"], "liver_function": [], "title": "Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.", "max_IF": 79.258, "min_IF": 59.558, "Sample Size": 203, "disease_history": ["Cirrhosis", "HIV genotype", "HCV genotype"], "Impact Factor": 69.41, "Data-Publication": 2015, "Citations": 355, "blood_test": ["CD4+"], "Tumor_test": [], "Test Items": ["CD4+"], "Journal": "N Engl J Med"}, "25195547": {"general_index": ["BMI", "Gender", "Age", "Waist circumference", "Race"], "liver_function": ["AST", "ALT", "CK", "LDL"], "title": "Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial.", "max_IF": 18.946, "min_IF": 10.59, "Sample Size": 34, "disease_history": ["Diabetes"], "Impact Factor": 14.77, "Data-Publication": 2015, "Citations": 119, "blood_test": ["Triglycerides", "cholesterol", "glucose"], "Tumor_test": [], "Test Items": ["AST", "ALT", "CK", "LDL", "Triglycerides", "cholesterol", "glucose"], "Journal": "J Hepatol"}, "26187031": {"general_index": ["BMI", "Gender", "Age", "Race"], "liver_function": [], "title": "Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study.", "max_IF": 27.516, "min_IF": 19.864, "Sample Size": 2112, "disease_history": ["HCV genotype"], "Impact Factor": 23.69, "Data-Publication": 2015, "Citations": 143, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Lancet Infect Dis"}, "28765706": {"general_index": ["BMI", "Gender", "Age"], "liver_function": ["AlkP", "Albumin", "ALP", "\u03b3-GTP", "ALT", "AST", "Bilirubin"], "title": "Non-invasive assessment of liver fibrosis using two-dimensional shear wave elastography in patients with autoimmune liver diseases", "max_IF": 3.411, "min_IF": 2.787, "Sample Size": 114, "disease_history": [], "Impact Factor": 3.1, "Data-Publication": 2017, "Citations": 7, "blood_test": ["Serum albumin", "PLT"], "Tumor_test": [], "Test Items": ["AlkP", "Albumin", "ALP", "\u03b3-GTP", "ALT", "AST", "Bilirubin", "Serum albumin", "PLT"], "Journal": "World J Gastroenterol"}, "26840694": {"general_index": ["Gender", "Age", "Race"], "liver_function": [], "title": "Achieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent   cirrhosis.", "max_IF": 4.237, "min_IF": 4.016, "Sample Size": 10, "disease_history": ["HCV genotype"], "Impact Factor": 4.13, "Data-Publication": 2016, "Citations": 27, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "J Viral Hepat"}, "26177866": {"general_index": ["Gender", "Age", "Race"], "liver_function": ["ALT", "HBeAg"], "title": "Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B", "max_IF": 9.13, "min_IF": 8.378, "Sample Size": 634, "disease_history": ["HBV"], "Impact Factor": 8.75, "Data-Publication": 2015, "Citations": 83, "blood_test": [], "Tumor_test": [], "Test Items": ["ALT", "HBeAg"], "Journal": "Cancer"}, "30345303": {"general_index": [], "liver_function": [], "title": "Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ-Based Quantitative Proteomic Analysis.", "max_IF": 2.583, "min_IF": 2.134, "Sample Size": 0, "disease_history": [], "Impact Factor": 2.36, "Data-Publication": 2018, "Citations": 1, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "Biomed Res Int"}, "25923596": {"general_index": ["Gender", "Age", "Race", "Region"], "liver_function": [], "title": "Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agents.", "max_IF": 2.089, "min_IF": 1.379, "Sample Size": 635, "disease_history": ["HIV genotype"], "Impact Factor": 1.73, "Data-Publication": 2015, "Citations": 5, "blood_test": [], "Tumor_test": [], "Test Items": [], "Journal": "HIV Clin Trials"}, "28939487": {"general_index": ["Age"], "liver_function": [], "title": "Plasma Heat Shock Protein 90alpha as a Biomarker for the Diagnosis of Liver Cancer: An Official, Large-scale, and Multicenter Clinical Trial", "max_IF": 6.68, "min_IF": 6.183, "Sample Size": 1647, "disease_history": ["HCC"], "Impact Factor": 6.43, "Data-Publication": 2017, "Citations": 11, "blood_test": [], "Tumor_test": ["AFP"], "Test Items": ["AFP"], "Journal": "EBioMedicine"}, "27694815": {"general_index": ["Gender", "Age"], "liver_function": ["AST", "Bilirubin", "ALT", "Albumin", "ALP"], "title": "Correlation of serum hepcidin levels with disease progression in hepatitis B virus-related disease assessed by nanopore film based assay.", "max_IF": 5.228, "min_IF": 4.011, "Sample Size": 66, "disease_history": ["HBV"], "Impact Factor": 4.62, "Data-Publication": 2016, "Citations": 12, "blood_test": [], "Tumor_test": [], "Test Items": ["AST", "Bilirubin", "ALT", "Albumin", "ALP"], "Journal": "Sci Rep"}}}